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PA RT A
STUDIES ON BIOCHENICAL CHANGES IN DIABETIC ANIMALS
ABSTRACT
Erythrocyte morphology and biochemistry were
compared between normal and diabetic rats. Echinocyte
formation were observed in diabetic ervw t!irocytes
Diabetic erythrocytes showed significant decreases in
mean corpuscular volume, mean corpuscular diameter,
surface area and surface area to volume ratio but
increase in mean corpuscular average thickness. These
morphological change and shape characteristics of diabetic
erythrocytes could be resumed by insulin treatment.
Enzymatic studies demonstrated that diabetic
erythrocytes contained significantly reduced glucose-6-
phosphate dehydrogenase, acetyl-cholines uerase and
pyruvate kinase activities r significant increase of
plasma N-acetyl- alucosaminidase activity was also
observed in diabetes M
Diabetic erythrocytes also showed significant
decrease in glucose uptake and low iT.L' content b The
cholesterol/phospnnoli pid ratio was significantly reduced
in diabetic erythrocyte membrane.,,,
Diabetic rats showed significant reduction in
spleen weights. i ymprocytes obtaining from spleen or
lymph nodes of diabetic rats demonstrated a greatly
reduced bias togenic response to Concanavalin A
stimulation,
Compared with normal ruts, did. oe ti c rats showed
great decreases of -a-trnino--n-butyric acid in pancreas
and brain cere oellurn and striatum, Tryptophan content
in the wnole Drain of diabetic rats were also signifi-
cantly lower than normal rats. However, no change on
whole brain serotonin content could be observed. The
in vitro uptake of -mamjrao-n-butyric acid, tryptophan
and serotonin of synaptosomal preparations were round
to be relatively the same in normal and diabetic rats
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Recent research strongly suggests that diabetes
is a heterogeneous group of diseases rather than
a single disease. Angiopathy, depre s s io n o f immune
system and neuropathy are frequently found associated
with diabetic patients (Oakley et al.,1978). Little
is known of the pathogenesis of these complications
associated with diabetes at present. Detailed informatiorMi
regarding the pathogenesis of diabetic animal model
is lacking.
As both streptozotocin and alloxan are specificJL -A-
agents in permanent destruction of pancreatic A cellsa. .l | - w
(Karunanayake et al.,1976; Kammarstrom et al.,1367),
experimental diabetes may thus be carried out and
-L.
the physiological responses and biochemical changes
are under investigation.
1. Studies of Morpho1ogy of Erythrocvte
..MM ...HiMTll n,—, , tt-r-r--r r r -r-n-—r.
In this thesis, change in morphology of erythrocyte
will be reported. Prior to finding out the causes of
this morphological change in d1abe t e s , factors that
play a role in affecting erythrocyte shape are briefly
review herewith.
Erythrocytes are considered to be composed of
three layers within their menbranes. They are (i)
an external layer of glycoproteins, containing the
b 1 ooa. group antigens „ Thi3 is probab 1 y a dis con 11 n-
uous layer, originating within the membrane and
extending out from tiie surf ace; ( ii) the ' clas.: ic '
doub1e nembrane structure, compos e d o£ the ohospho1ioid7 Jl. . 1. _i_
bi 1 ayer s tabilized bv choles tero 1 • This 730rtion
0 f t he m e m b r a n e a 1 s o c o n t a i n s c e r t a i n p r o 10 i n s ;
(iii) a layer 0f pr01eins a11ached 10 or extending
f r 0 rn t h e d 0 u b 10 m e m b r a n e i n 10 t h e i n t e r .1. o r 0 f
the cell.
During the last decade much, progress has beenJ „C 1—'
made in the biochemical characterization of the
various pr0tein, g 1 yc0protein and 1 ipid co 11 stituents
of the membrane, Ghoy et ral. (1979) reported'that
aged erythrocytes showed a decrease in sialic acid
011 their external layer as compared with young cells
Bessis and Mohandas (1975) reported that the
cholesterolphospholipid (CP) ratio of the hilayer
is an imoortant factor affecting the morohologyJ_ —' - —? Xj
n t p -n 1; +• To V o r T P rP To p p yv T V; T P o o r ~~ p p f; I1 p y ss c; 1 y fj o r(vT -J- - h i. _J . v v' - jb _i_ .u 'v- ——Cy J. 1. -X U O ' -X —~ —'•—-—-N •—X«. V- v.. J1
as a pleomorphic entity that the biconcave shape
of normal erythrocyte i.e. disoocyte results
from a delicate equilibrium of forces (Weinstein,
1 974)
-f ,0 j y- J 9
The discocyte can be induced to assume various
configurations in vitro . The mostly widely studiednwnwnMM'mtammammmmrmutfUiimtiimBt
are the discocyte-echinocyte transformation.
During this transformation, the shape changes
from.a -biconcave disc to a crenated sphere with
spicules distributed over the surface (Bessis,
1973) . This transformation can be induced by
many factors, among them call aging, intracellular
ATP depletion and treatment resulting changes
of lipid composition of bilayer of erythrocyte
membrane .Ifa-kao et al,, iyt2; Hartmann, 1977).
2. ImmunoI.ogie Feature of Diabetesiimii—iiiii Himin miii HiinnnwnnnnMimrni nr—iiniiiin
Clinically, increased susceptibility of diabetic
patients to bacterial and mycotic infections is
well documented (Casey et al. ,1977.) Depression
of lymphocyte response to antigen has also been
noted in diabetic patients (Bagdade et al.,1978)«
In animal studies, streptozotocin-induced diabetic
mice have been reported to possess a great decrease
in the size of lymphoid tissues such as spleen
and thymus (Nichols et ad.., 1979) • Delay pro 1 if era t.
-ion and differentiation of lymphoid cells are
also observed in diabetic mice (ishibashi et al.,
1980).
3• Neurological Feature of Diabetes»u« —— »hiii«iwi nmcmoii—mini
Neurological disorders are frequent major
complications of human diabetes Colonic dilatation
and loss of fecal consistency are the major
syndroroes . Mos t recen11 y, 3chrnidt e t a 1 „ {1Q81)
reported that degenerating unmyelinated axons
w ere o b s e rve d in s t r ep tozot o cin-induc ed diab etic
rat s. C randa11 and Fernstram (1980) a1so aemo n -
strated that streptozotocin-induced diabetic rats
were unable to experience normal carbohydrate-
induced increments in brain serotonin and tryoto-«v-U
p h a n. T a rii g u c hi e_t al. (19 7 9} a n d 1 ex be r et al 0
{1979) observed that paneredtic is1ets in rats
treated with strptozotoein would exert a great
decrease of Y™ amino - butyric acid {1a3A) to
about one-tenth of the control level after 24
hours . 1A3a is a c1ass of inhibitory neuro-
%
transmitter. Although its exact function on the
pancreatic islets is still obscure, study of
its concentration in the brain of diabetic animals
Is of great interest.'—J
40 Purpose of Study
Clinic a 11 y 9 r e d u c e d e r y t hr o c y t e d e f o r m a Id i 1 i t y
has been reported in diabetic patients (Schmid-
»
3 c h o nb e i n a n d V o Iyer ,197 6) . E r y t hr o c y t e d ef or in -
ability is a measurement of the geoinetric ani
physical characterization of the erythrocyte
that permit the cell to pass through the ana torn-
o p o 1 gr p o f~ y» i o p ul o rr or q ,- g -j- h, tod i o v p o o y p P 'r o r o
_L C_- j L j -L. h u-u -t. O -L C- _u O JL.i.0 el -L 0.uv i' 1 _L h- a. j P .j. _L h •0- U i. L) a i „
T ~r 7- -p q o 1 cq p }p p p }p -p .3 rn n p T £ To ~ r o T hi P ~f~ i p g r p Q r o r- p r ,p ~p pjL. jol vn CU-i,.. -_D_y -0 v. v.' -i.-h h' »P•-—0 'v-'- v.-;- h- v v_ J h a. _I_, . X v —j0 _u. , , x 0 -i—»—D
-L '
that erythrocytes in the disoocyte form are more
deformable and in the echinocyta form are less
deformahle ( Bessis and Mohandas,1975)• However,
the incidence of echinocyte in diabetic patients
has not yet been reported.
Invetigation on clinical diabetes always
encounters many great difficulties, most of thet—j
cases under study are maturity-onset obesity-j v
induced diabetes. The patients may have - '
normal plasma insulin content, only the insulin
receptors of the adipose tissues are reduced
as compared with control (Oakley et al.,1375)-
The aetiology;,-of this group is quite different
from the juvenile-onset diabetes which is known
to he associated with lacking of insulin.
Furthermore, elinleal corap1ications are frequent-
1 v o b s e r v e d i n d i a b e t e s „ I f t h e p a t i e n t s ha v eX
already on drugs or insulin therapy, the
diseased conditions are more difficult to
control
The aim of our study is to utilize an animal
model to clarify the biochemical features
associated with diabetes. Our study will be
be divided into three oarts:-
(a) Morphology of Erythrocyte of Diabetic Rathbmwwn'tinAmimunn,,r,nunmnwnwnwiii7!)Hmniii»»iinr.-»wiwrrir«n-«irii'»r(r»?iiT«riin-iwTimri r-n-nim-Hi-n-iri-Tinwf•i- r-Tm-mmT-rrfii-Tunrni-rTin-ii-rtn-irmi-i-m—m-r- wri—
The morphological change of erythrocyte will
be tested0 8ince three factors, namely aging,
intracellular ATP depletion and lipid changes
of erythrocyte ( Nakao et a1, 1962; Hartmann,
1977)? have been cited to be the major reasons
that precipitate echinocyte formation, the
influence of these factors on erythrocyte
of diabetes will be studied.
The activities of glucose-6-phosenate-V_J L _X
dehydro :enese _nd acety1cho1inesterase which
are the enzyme markers of aging will be mease-red.
0andidates that affect ATP coreentration, i.e,
glucose uptake . n:1 activities of glucose metabolic
enzvmes - f erythrocyte w111 a 1 so be ex-minec:.v.- U V
Finally, the cholesterolphospholiold ratio
o f e ry t hr o c y t e m e nib ran e w i 11 b e t a a t e a
(b) immunologic Feature of Diabetic Hat
B1 as toaenic res oonse of 1 yinohocy tea oktainingV ? ..I .... J '
from s pioon and Ivrnoh nodes to Concanava 1 in A,C Kt
( Co n A) wi 11 be e xarnine d . Mi t o g e n- i n 1 u c •:• d
biastogenssis of lymphocytes is a common index tc
Z v p '34 -p ~}- o. mo ] 1 —.7TIP 1 P f P '1 1 ynro'pTop v» o c p y yi eg p p -p 7- '-a o—).—'U 11 . v —-I_ _i» 11 J. v.' ei.. L. A «_ v. J, _i_ , •, j. „ 1 hi. -i. %—-—-.0 - --_y j. uAv_- l j.
animal (Ho et al. , 1878).
( c) 11euro 10 yica 1 Fea ture of Diabe tic Rat
Decrease GaBa content in pancreatic tic ;ue i.as
recen11 y been re por ted 10 be reduced in s tre 01oz01ocn-
induced di•~betic m 1 ce (Taniguchi et al. , 1979 ;
G-erber et al., 1979). We will investigate whether
same change occurs in diabetic rat. The content of
• s0me amin0 acid neurotransmitters, namely GaB21,1
tryptophan and serotonin in brain will be
o v ;-i rn 1 id p P 1!1 h p i t i i o +• p V o rr fa p h p r- p rn q jyr t n pv—Ji i o- -1 .w a- V i. 4. A .4. J- O C-A. 1; i. -Lvl-s, 1 : 4. .J y jl jLx kJ
synaptosomal (P2) pre para tiions of the brain tis sues
will also be elucidated.
II. Materials and Methods
—i—WIIIOTTmrmMtrnmw—cwi«MWnwn—h»HHI»« —trmm»
1. Induction of Diabetes
(a) Induction by Streptozotocin
The induction of diabetes was performed as
described by Levine, et al. (1978), with slight
modification,
Male rats weighing approximately 340g were used.
Diabetes was induced by intraperitoneal streeto-
sotocin injection. 3treptozotocin (Sigma No.S-0130)
was dissolved in 0.5 ml of sodium citrate buffer
(10 mM, pH4.5) at a concentration of 100 mgKg
body weight. At 48 hours after injection, urine
was drawn from the rat and urinalysis was carried
out by dipping the clinistix reagent strip into
urine. Clinistix reagent strips (Product code
N0.2847) w h i c h a re orig i rial. 1 y d esi gn e d f o r t e s t i n g
urine glucose clinically were available from
Ames Company. All rats of urine glucose concentrat¬
ion greater than 2gdl were used in the following
experiment.
(b) Induction by Alloxan
The method as described by Morgan and Lazarov (1965)
was used. Male rats weighing about 340g were admin¬
istered alloxan at a concentration of lOOmgKg body
weight in 0,5ml saline (0.9 % NaCl) by intraperitonea
injection. Diabetes was developed after 96 hours of
inipntin n.
2» G-lucose Tolerance Test
The method as described by Metz et al. (1970) -as
ijspci with si inht mod1fication.
Normal and diabetic rats were fasted 24 hours before
experiment, Blood was drawn from tail vein for the
determination of fasting plasma glucose concentrat¬
ion. Grlucose saline solution (ISOmg lOOg body
weight) in volumes of 0,5ml was then injected intra-
peritoneally, Blood was then drawn 10, 50, 60, 120
minut e s after in j e c tio n e
Plasma glucose concentration was determined by
glucose oxidase method as' described by Keston (1956),
Commercial kit obtaining from Sigma Company (Product
No. 65 5-100) was used.
S PlpQmp IriQi i i in fnnnori+rati nri
The abilities of insulin secretion in response zo
glucose concentration in vivo in normal and diabetic
rats were tested.
Normal and diabetic rats were fasted 24 hours
before experiment. Blood was drawn from tail vein
for the determination of fasting plasma insulin
concentration. Glucose saline solution (I80mg
lOOg body weight) in a volume of 0.5ml was admin¬
istered intraperitoneally. Blood was drawn 10, 20,
30, 60 minutes after inje c tion.
Plasma insulin concentration was determined by
using a radioimmunoassay kit (Code IM 78, The
Radiochemical Centre, Amersham Buckinghamshire,
England.) Method by Midgley et al. (1969) was
f o 11 o w e d.
4 Insulin Treatment of Diabetic Rat
The method as described by Hoskins et al. (1979)
was used with modification. Insulin (Sigma No.
1-3505) was dissolved in 0.9% NaCi at a concentrat¬
ion of 20 I.U.ml. Diabetes of rats was induced
i
by streptozotocin injection as described before.
Insulin treatment was carried out immediately after
streptozotocin injection. 0.5ml of the insulin
solution was injected subcutaneouslv to the
diabetic rat. The injection was repeated daily
for 14 days.
5. Morphological Studies of Erythrocytes of Diabetic Rat
va) -Erythrocyte • Morphology
Blood was diluted two hundred fold with a solution
of 0.2.50 bovine serum albumin in 0.01M phosphate-4 -A.
buffer, pH 74, Erythrocyte numbers were determined
by a hematocytorneter The erythrocyte morphology
was observed under light microscope (Hsu et al., 1980).
(b) Determination of Blood Volume of Normal Rat
In order to assess the effect of streptozotocin
and a1loxan o n e rythro cy t e in vitro, he pariniz e dmirrnrrtmimwu»»«—J'n'
blood was incubated with both diabetogens and the
morphology of erythrocytes was observed after
incubation. Blood volume of rat was estimated so
that the incubating concentrations of diabetogensw '
would approximately be equal to that in vivo
would be used.
The method as described by Selcher et al. (1957)
was used. Rat was anaesthetized by i.p. injection
of pentobarbital (24mg Kg body weight). The rat
was dissected arid carotid artery was found. Then
the artery was catherized and 0.5ml 1-131 albumin
solution was administered into the animal through
the fastened catheter. 0.5ml saline was injected
through the catheter to wash all the radioactive
solution into the rat. Then the radioactive solution
was allowed to mix through the blood circulation
for 10 minutes. After mixing, the blood was drawn
from the posterior vena cava into a heparin.!zed
t est tube. 0.5ml blood s a r:i p 1 e w a s u s e d f o r
counting activity with the counter (Gamma 4,000
Beckman). The activity of 0,5ml 1-131 albumin
solution was measured as well and its soecificJL
activity was determined and expressed as corn ml,Jl. t
The blood volume of the rat was calculated by






where Ai = activity of tracer
Vi = volume of tracer applied
Yr = blood volume of animal
Si - specific activity of standardX.
( Ai Vi )
Sr = Ai (Yi + Yr), specific activity
of the animal's blood
6. Determination of the Erythrocyte Size
(a) Mean Corpuscular Yoiume ( MCY )
MCY was determined by centrifuging cells in
a capillary tube with, volume markings. With the
cell number determined by hematocytometer, the
mean corpuscular volume was calculated, by the
f o 11 o w i ng e qua t i o n (I nwo o d r, 19 7 6) :
(b) Mean Corpuscular Diameter ( MOD )iTHM—inwarn.I —uw»!!nWwnf«win«.iMiif wI emmWiMX—I——wwww-1 n mdWft Wi a wo«t—u
MOD was determined by using a microscope
eyepiece fitted with a calibrated ocular micrometer.
Each time 100 red cells were measured and the
diameter taken to be the average diameter
of 100 cells.
( c) Mean Corpu.scu 1.ar Average Thickness ( MCAT ) and
surface area
MGAT and surface area were calculated from
the data of MGV and MOD assuming that the red
cell was a short disc (Inwood, 1976).
7• Determination of Hemoglobin (HP)
Slood hemoglobin was determined by using
commercial kit (Sigma Kit No. 525) which based
on the method of Stadie (1920) . 2qgtl blood was
pipetted into the tube containing 5ml of Drabkinrs
solution and rinsed for several times. The mixture
was allowed to stand for 15 minutes, and absorbance
at 540nrn was recorded. Human met hemoglobin was used
as standard.
8. Determination of (llueose~6~?hosphate Dehydrogenase
.i»»—ihhi»w.'i nin!'!nni.nimiII .Millmiimi imrwiufwuMhirmnrrrmmrirmuiinnnirn~«iirrrnnm-iTrini ii —«ir.i Mrrrhthit-rmrinnn•Ti~r—m-i—m»imi ni i hii i i i i»i«hi mui wf•'rrinn .n«mtiinni«wino.
( G--6-P-DH ) Activity of Ervthrocvte
.,1 „„ r nr- ~ M -
The method as described by Lohr Waller (1974)
was used. Test kit is available from Sigma Co.
(Kit No. 345-U'V). To cuvets 1ml reconstituted
Gr-6-P-DH reagent was added with lOp.1 packed
eryth.rocyte . Erythroeytes were completely suspended
and allowed to stand for 5 minutes. 2ml G—6-P-DH
substrate was added and mixed. Initial absorbance
was read at 340nm. Exactly 5 minutes later, final
absorbance was again recorded. Enzyme activity
was calculated by using the following formula :




where TCP = temparature correction factor
Experimental temperature was recorded and the
corresponding TOE values providing from theX J X ..0
manufacturer were us ed f or c-a 1 cu 1 ati on.
9 Determination of Acetylcholinesterase ( AchE )
Activity of Erythrocyte.
The method described by Ellman et al, (1961)
was usea. The enzyme activit v is measured bvW 'J sJ
following the increase of yellow color produced
from t hi o choline when it reacts with 5 , 5 9 -d it hi o«~
bis-(2-nitrobenzoic acid) (DTNB), It is based on
coupling of these reactions :
A c e t y t h i o c h o 1 i n e
AchE
thiocholine a acetate
t hi o c ho 1 i n e + DTNB yellow color
Erythrocytes were diluted by 1 : 600 with posphate«
buffer (pH8.0 , 0.1M). Exactly 3,0ml of the
suspension were pipetted into a cuvette, lOpil
of 0.1% quinidine sulfate was added to inhibit •
plasma esterase. 25yi 1 of DTNB reagent (0.01M in
0.1M phosphate buffer, pH7.0 with 0,15% NaHCO)
were; added. After adding 20pil of substrate
(acetyl-thiocholine iodide, 0.075M), the changes
in absorbance ( A A) at 412nm were recorded for
at least 6 minutes. Enzyme activi ty was ca 1 cu 1 a.ted
by the foliowing formula :V- '




10. Determination of Glutathione ( GSH ) of Erythrocytes—m mwill I min III mum—mi——W»immiimiinmwnwm—ill —WlMUMi i nw—BmmiiWT—wn» ama- nunI mi nuniiimiii unmn' • nui n.nnmwni'mi.i i I
The method as described by Beu11er et al. (1963)
was used. Preliminar v exoeriments showed that•D a,
plasma contain no glutathione so that whole blood
was used to measure GSH of erythrocytes. 0.7ml of
water was added, to 0.3ml of heparinized blood. 2ml
of precipitating solution was added. (Precipitating
solution was prepared by dissolving 1.67g glacial
metaphosphoric acid, 0.2g -Ha0EDTA and 30g NaCl perMl
100ml of HoO) After standing for 5 minutes, the
mixture was centrifuged lml of supernatant was
mixed with 3ml of 0.3M phosphate buffer. 0,5ml
of 0.4% 5, 5 !'»dithiobis~(2-nitrobenzoic acid) in
0.3M phosphate buffer was then added. After standing
for 5 minutes, the samples were read at 412nm. Reduced
glutathione (Sigma Co, USA) was used as standard.
11. Lipid Extraction of Erythrocy t
(a) Extraction of lipid from erythrocyte
The method described by Rose and Oklande:o
(1965) was used.
The he pari ni zed blood was collected, and
centrifuged at 1000 xg for 15 minutes. The
packed cells were washed three times with 5
volumes of 0,9% NaCl. After washing, lml packed
erythrocytes was a dded to a 30-ml screw canj KJ -L
centrifuge tube. The mixture was allowed to
stand for 15 minu t e s. Then 11ml iso pro pano1
was slowly added. After 1 hour with occasional
shaking, 7ml chloroform was added and shaken
occasionally for further 1 hour. The aliquot
was used for quantitative determination of
pho s pho1ipid and c ho1e s t e ro1.
(b) I)etermi.nation of Gho 1 estero 1
The method described by Leffler (1959) was
used, lml of lipid extract from erythrocytes
was pipetted into a 16 x 125mm screw cap culture
tube. Then 2ml of aqueous color reagent vas
carefully dispensed, into the culture tube so
that two layers were formed in the final mixture.
The tube was capped and the content was mixed
18
by inverting four times. After mi xing, the cap
was loosened. The mixture was allowed t''Uo stand
for 10 minutes for cooling and absorbance was
read exactly 10 minutes of ter inverting sample.
Cholesterol standard was dissolved in isopropa.nol
and a standard curve was obtained following the
above procedure,
Color reagent was prepared 110y did. uting 8ml of
the iron stock Solution (2.5g I eCl3 6H2O was
dissolved in IOOmI of 87% phosphoric acid) to
loom! with concentrated H 9 SOA
c Determination of -ohosph.oi lplcl
The method described by Sperry (1942) was used.
lml of lipid extract from erythrocytes was pipe t ted
into 13 x 150 mm glass pyrex tube. The solvent was
evaporated off under a gent?.e stream of nitrogen
in. a heat block maintained at approximately 60-
70°C, lmi_ digestion solution (51T H2SO4 containing
35% perchlori c, acid) was then added and the tube
was placed on a heating block at 200 to 300°C for
20 minutes. White fumes could be observed when
the digestion process was ended. The tube was
cooled at room temperature for about 5 minutes.
2ml,- i ry t. 1 i e water was then added. After mixing
lml of 3o molybdate solution and 2 ml of semi dine
reagent (50mg in 100ml of 1% NaHSO-z) were added
and the tube was agitated. After incubation at
50°C for 15 minutes., absorbance was read at 770nm„
Phosphatidy 1 choline was used as staridard. It was
diluted with chloroform at 0.05 to Img in 1ml.
The determination procedures as described above
were followed.
12, Glucose Uptake in ErythrocyteT—T--!!-ii——ft -C-—1,...,.„.rmlKr,-rn,r-fftnr-r,n,.-!-vrlftr-VS—in--—i
Heparinized blood was collected and centrifuge!
at 1000 xg for 15 minutes. After centrif ligation,
the plasma was aspirated, the cell pellet was
washed three times with Cm9% NaCl to remove
leukocytes, platelets and substances or debris
o ther tban ervthro c.vte s .
The method for measuring glucose uptake is
based on the similarity in kinetics of radiolabeled
2-deoxy-D-glucose and D-glucose transport across
the cell membraneand takes advantage of the
factthat 2-deoxy-D-glucose cannot be metabolized
after phosphorylation (Sinha et al., 1981),
0.1ml of packed erythrocyte was pipetted into
a microcentrifuge tube (Sarstedt, Germany) which
contained 0.23ml of physiological phosphate -
buffered saline, pK7.4, with 1% BSA, and 0,1ml
of 5QuM glucose. After mixing, 0.07ml of
2(1, 2- H) deoxy-D-g'lucose (5 Ciml) was added.
After 20 minutes incubation, ice-cold phosphate
buffered saline was added and the tube was
immediately centrifuge! with Eppendorf micro¬
centrifuge. Erythrocytes were then lyzed by
adding 0o5ml water and allowed to stand for
15 minutes, The hemog1obin was precipitated
by adding 0.5ml of 12% tric hioroacetic acid.
After a further centr if ligation, the resulting
supernatant was used to determine radioactivity
with 1iquid scinti11ation counter. Erythrocyte
number was determined by using a hematocytometer.
Q
Glucose uptake was expressed as corn 10 cell
per minute.
15. Determination of Phosuhofructokinase ( PFK )I .uminwnIII ininnIII I Iii.inimninmwi i WM»B.i.nnmiiujn».wf....n aMrgm—•nwmmm. ii.i.ini.iii . .t.wMiniMB.p.wroimil.... o-omrCwi
Activity of Erythrocyte
The method as described by Mansour (1966)
was used. 33raM Tris-Hcl (pHS), 5mM MgS0, 50mM K01,
ImM dithiothreitol, 2mM frutose-6-phosphate,
2mM ATP, 0.16mM NADH, and 0.2ml enzyme mixture
were mixed and made to total volume of 3ml with
distilled Ho0 . lOjul packed erythrocytes washi
ripetted into the tube and the change of absorbance.1. .1
at 340nm for 10 minutes was read. The enzyme
activity was expressed as unitglib . The enzyme
unit is defined as amo 1 e of fructose-1,
6-ddiphosphate (F-l, 6-DP) being produced per
minute. The rate of disappearance of NADH is
followed spectrophotometrically at a wavelength
of 340nm. One micromole of F-l,6-DP is equivalent
to two micromoles of NADH oxidized. Since the
millimolar absorptivity of NADH is 6,22, the
amount of NADH being oxidized is calculated by
Beer's Law, and thus the amount of F-l,6-DP
formed can be evaluated.
Enzyme mixture was prepared by mixing 0.25ml
aldo1as e (100 unit sml, Sigma ho. A ~ 714 5),
0.05ml of of -glycerophosphate dehydrogenase
and triose phosphate isomerase mixture (lOmgml,
S igrna No , G—1881) , and 4 • 7ml BSA (10mg4.7ml)
14. Determination of Pyruvate Kinase ( PK ) Activity1-HWIHIIii11—II ——nil111!—M[immrnmniiii an—i mii mi nni i 11mmmm«»mmmvui wmm—.i ,mm»mmt wm»t wrnrmmmHi ,miimm—ninpithiih»mmi »miai—
of Erythrocyte
The method as described by Valentine and
Tanaka (1966) was used,
0.5ml of 0.05M triethano1amine-HG1 buffer
(pH7.5), 1.2ml water, 0.1ml of 2.25M KC1,
0.1ml of 0.24M MgSO,, 0.2ml of 0.006M AD?,
't
0,1ml of lactic dehydrogenase (180 unitsml),
0,4ml of 1.4mM NADH, 0,01ml of pack erythrocyte
(heparin!zed blood being wasned three times
vith saline) were mixed. Then 0,1ml of 0.045M
phosphoeno1pyruvate (trisodium salt) was added.
The reaction began just after the substrate
phosphoenclpyruvic acid was added into the
assay mixture. Readings were taken at time
interva1s and recorded for 14 minutes, The
change in absorbance occurring between the
4th and 14th minute was usually used for
calculation. Rabbit muscle pyruvate kinase
(Sigma No. P-1381) was used as standard.
15» Determination of ATP of Erythrocyte
ATP (adenosine-1-triphosphate) kit obtaining
from Sigma (code No. 366-UV) was used to evaluate
ATP content in erythrocytes. The method based on
the. reaction between 3-phosphoglycerate and ATP
catalyzed by phosphoglycerate kinase. This reaction
was coupled with a dephosphorylation reaction that
involved the oxidation of NADH. Formation of NAD
was then quantitated by measuring the change in
absorbance at 340nm. (Adams, 1963)• In preliminary
experiments, it has been found that plasma contains
no ATP. Whole blood was then used to determine AT?
of erythrocytes without separation from plasma.
Into a centrifuge tube, 1ml 12%TCA was pipetted
and lml freshly drawn heparinized blood was added.
The mixture was centrifuged. at 1000 xg for 5-10 min.
and the clear supernatant was used to quantitate ATP.
To 0.5ml supernatant, lml phosphoglycerate buffer
(Sigma Stock No. 366-1), 1.2ml H.0 and 0.3ml NADH
(1mgm1) we re added. Af t er mixing, t he initia1
absorbance was read at 340nm. After recording the
initial absorbance, 0.04ml G-APBPG-K enzyme mixture
(Sigma Stock No. 366-2) was added. The decrease in
absorbance wou1d be ende d within several minutes
At 5 minutes after adding the enzyme mixture, the;
final absorbance at the same wavelength was recorded.
The change of absorbance (A A) was calculated by
substracting the final absorbance from the initial
one. ATP content was expressed, as yumoleg, hemoglobin
and was calculated by employing the following formula
riemoglobin ATP Qumoleg)
A x 195
B1 oo d hemogloT)InTgTTOOnffj
16. Determination of Plasma N-Acetyl- 3 -glucosaminidase— mMW '.I'll I . I 1W I IlliWiin I..1.II II ..Ill i'« 1.11. I.L m
The activity of N-acetyl- {Z -glucosaminidase
was determined according to the method of Leaback
and W a 1 k e r (1.961) w i t h s 1 i g h t m o d i f i c a t ion. A 0.1ml
aliquot of plasma was mixed with an equal volume-X- -i- «-L
of substrate solution containing 2.5mM of
4 - m e t hyl u mb e 1 life r o n e - N - a c e t y 1 - (2 - g 1 u cosa i n ine i n
0.1H Sodium citrate buffer, pH5.0 . The mixture
was incubated at 37°C for 50 min. The reaction
was then terminated by adding 3ml of 0.5M glycine
b u ffer, p H10.6 . The amount of f1uo re s c e nce develope d
by the release of 4-methy 1 umbelliferone was meas.ured.
The excitation and emission wavelengths were 358n.m
and 418nm respectively. The amount of 4-methylurnbe11iferone
released was read against a standard curve oreoared'»• s -J- J.
simultaneously with the samples. Enzvme activityW ~L 1 J
was expressed as ng 4-methylumbelliferone liberated
oer minute.
17» Biastogenesis
The method as described by Ho et al, (1979) was
us e d.
Normal and diabetic rats were decapitated. The
following procedures were done in sterilized
condition. The lymph node and spleen were carefully
taken to the disc containing medium. The medium was
as follow : PPMI 1640 culture medium ( KG Biological
Lenexa, Kansas, Cat. DM~319 ) supplemented with 25
mM HEPBS buffer (pH 7.4 ), 200 mM L-glutamine,
penicillin-streptomyc i n (100 u n i t s rn 1 ) , m y c o s t a tin
( 0.2 mllOOrnl), gent amy cin ( 20-gml ) and 1.0' (vv)
heat inactivated fetal calf serum. Spleens or lymph
nodes were meshed and the cell debris was removed after
a quick spin . Erythrocytes were separated by washing
the cell suspension with ACT solution ( 10 ml of 0.17M
Tris + 90 ml of 0.16 M ammonium chloride, pH 7.2 )
Then the cell pellet was resuspended iri the medium
and cell number was det ermined. Viable cell number
6
being adjusted to 5 x 10 per ml was used.
0.18 ml of the cell suspension was added to the wells
of the plate ( each sample triplicate ). Then 0.02 ml-i. -L
of Con can aval in A ( ISygml for spleen, 9tgml for
lymph node ) was added . Control 'contained medium
instead of Concanavalin A. After 48 hours, 0.02 ml
of HI-thymidine ( 25yw Ciml ) was added to the
wells. The cells were harvested 6 hours later on
glass fiber filters ( Whatman GFC ). The radioactivity
retained on the filters was determined by liquid
s c 1 n ui 11 citiot 1 counting• Tug (Icifcct xhGpoxbG(I us Llic
net stimulation (cpm) of the incorporation of
'7
( H) - thymidine in the preserice of 0oncanava 1 in A
• Determination of y -Amino-n-butyric Acid. (GABA)
in Rat Brain arid pancreas
Normal and diabetic rats were fasted 2.4- hours
before decapitated. The brain was removed. The
cerebral cortex, cerebellum, striatum and pancreas
were dissected out and weighed. The weighed portions
were individually hernogenized in 2ml of 1M
trichloroacetic acid (TCA) and centrifuge! at
10,000 xg» The resulting supernatant was reserved
for GABA determination. GABA contents were' determined
by the method described by Okada et al. (1976).
The principle is based on the reduction of NADP
as described by the following :
(A) -amino-n-butyrate -a oL -ketoglutarate
n A ~Q mVXi1JDATX Succinic semialdehyde + glutamate
(B) Succinic semialdehyde + NADP+
S3DH a
succinate +NADPH + H
Gabase (Sigma No. G-7509), a mixture of y-amino-
butyric g 1 u t a in i c t r a n 3 a m i n a. 3 e ( G- AB G- T) a n d s uccinic
semialdehyde dehydrogenase (SSDH), was used in this
experiments„
0.25ml p yr 0 p ho 3 pha t e (0.1 M, p H8.6) , 0.2 ml NALP
(4mM, pK7 »0) and 0. 1ml G-abas e (3 units ml) were
added to 0.1ml supernatant. After initial absor'bance
at 34-Onm had been recorded, 0.2ml sodium- cA -ketoglutarate
(0.02M, pH7.9) was added with gen11e mixing and
incubation 0vernight at r00n temperature. Pinal
absorbance at 340nm was taken. The standard curve
was obtained by using G-ABA standard solution instead
of the supernatant under the same condition.
19 (a) Determination of Serotonin (5-HT) in -Bat Brain
The method as described by Ourzon and Green (1970)
was used.
The whole brain of rat was homogenized in 10 vol.
of cold acidified n-butanol (0.8ml conc.HCl : 1ml
n-butanol) using Telfon homogenizer. After centrifugation
for 5 min. at 1000 xg, 2.5rnl of the supernatant was
pipetted into a 15ml glass stoppered tube and shaken
mechanically for 5 min. with 5ml n-heptane and 0,4ml
0.1N HC1 containing 0.1% L-cysteine. Aqueous and
organic phases were then separated.
To determine 5HT, 0.1ml samples of the aqueous
phase were pipetted into 12 x 125:Tim tes t tubes .«L JL
0.6ml of 0.004% o-phthalaldehyde (OPT) in ION HC1
«
were then added. After mixing and. heating in a boiling
water both for 15 min. the tubes were cooled in waster
and fluorescence were measured using a spectrof1uorometer.
Activati o n and f 1 u.ors c ene e wave 1 eng th s were 3 60nm and
470nm respectively. Standards were prepared by diluting
s to c;: s tandard aqueous so 1 utio n o f 6Op.gm 1 (s tore d
at -25°G until used)by 100 fold with 0.1N HOI
centalning 0.1o cysteine. 0.1 m 1 of the d11 ut-ed
standard was reacted with 0.6ml of the 0.004% OPT
in HC1 solution. Blanks were prepared by reacting
0.6ml of the OPT solution with 0.1ml HC1-cysteine
s o 1 u t i o n o nl y.
19 (b) Determination of Tryptophan in Hat Brain
Method of Denkla and Dewey (1974) was used,
Whole brain weighed about 2g was homogenized in
5.0ml of icecold 12% (WV) TGA. The homogenate
was centrifuged at 4°G and 10Oyil of the supernatant
was added to 2.0ml of cold 10% TGA for the assay.
For the standard curve, stock tryptophan standard
solution was diluted to a concentration of 20nmolesml
with 0.1N NHtOH and aliauots containing uo to 2nmol.es
were added to 2.Oml of 10% T OA To each protein-free
sample on ice or standard was added 0,2ml of 2.0%
(WV) formaldehyde. Immediately before transferring
each tube to the boiling water bath, 0.1ml of 6.0 x 10~
FeCl in 10% TCA was rapidly added and mixed.
After heating the samples and standards and making
t h e m u p to volu rn e , their f 1 u ores c ence w a a m e a sured
using a soectrof1uo rom e te r.v..
20 Neurotransmitter Uptake in Brain
(a) Preparation of Synatosomal (or ,p0) Fraction
Vhole brain or tissues from various regions of the
rat brain, e.g. cerebral cortex, cerebellum, striatum,
were weighed and homogenized in 10 volumes of ice-cold
0.32 M 3 u c r o s e , u s i n g a g 1 a s s h o rn o g e n i z e r w i t h a T e 1 f o n
»
pestle (radial clearance = 0.10 - 0.15mm). The
homorenates were centrifuge! at lOOOxg in the cold forJ v...J « '
10 minutes to remove unbroken tissue fragments and other
cell debris. The supernatant was retained for further
centrifugation at 100,OOOxg for 20 minutes at 40C whlie
the pellet was discarded. After centrifugation the
resulting pellet was 'suspended in Krebs-Ringer incubation
solution with wet weight to volume ratio of 1:20.
This preparation was assignaled as fraction or the
synaptosomal fraction as originally described by
Iversen et al. (1971).
Incubation solutio11 wa3 prepared by adding 0.2ml
of 5X Krebs-Ringer s01ution (0.72M NaCl, 0.03M K01»
7.2 mM MgSO., 7.7 mil CaCi0) with 0.1ml of 0. 1M
glucose, 0.1ml of 0.IK phosphate buffer (pK7.2)
and 0.6ml Ho0 to a volume of 1ml.C-
(b) Uptake of Neurotransmitters in Brain Pn Fraction' Wim..l.1li II..— I I I. II ......I 1. . ...... - . I. y' I I , I. I »» ... .
CD}'• o T T ' b ~i—i ro o
_i_«._|.yati_'v.,t0v.' -i i.. 0CgW»wfo oaiKftpi v—i »11»—i njivUPJH
The meth0d as iescribed by Iversen (1971) was used.
Uptake of G-ABA, Serotonin, tryptophan by synaptosomal
(0r P9) fractions prepared fr0m who1e brain 0r cere bra1£
cortex, cerebellum, and striatum of rat brain were
determined.
, A
In each case, 0.05ml of tritiated ( K—) neurotransmi11er
was added to a microcentrifuge tube containing 0.85ml
synaptosomal fraction and 0,1ml H90, The mixture wast'n
incubated at 250C in water bath for 30 minutes. Tubes
were then centrifuged for 2.5 minutes in an Eppendorf
centrifuge. The supernatant was removed with dropper.
After further centrifugation, the supernatant was
care f ul1y re mov e d wit h mic r0 pipe1t e. The dry pellet wa s
dissolved w 11h 0.5ml 1 Q% sodium d0decy 1 su 1 fate (31)3)
for 24 hours. The dissolved synaptosomal fraction v;as
used for protein determination (Lowry, 1951) and toe
radioactivity was determined by usiny liquid scintiliatie:
c o un• t e r. Up take o f ne uro trans rni 11 er was expr e s s e d as
com per my protein of svnatosomal fraction.-L v—? A.
Ill. Results
1. Induction of Diabetes
Experimental diabetes was induced in male rats
weighing 300-350g by intraperitoneal (i . p,) injection
of streptozocin (100ragKg bod.y wt) fresh 1 y dIs s o 1 ved
in approximately 0.5ml of a 0.9% n'aCl solution (saline)
in 0.0 5M citrate (pH4.2). Ano ther diabetogen, a11o xa n,
with the same concentration -s streptoso toein but
dissolved in saline instead of citrate was also used.
It has been reported that diabetes would be developed
48 hours after injection of streptozotocin (Levine, 1978}
and 96 hours after injection of alloxan {Morgan and
Lazarow, 1965).
Overnight-fasted plasma glucose concentrations wereCO ~l c_o
then determined to ensure development of diabetes. As
_L
shown in Table 1, both diabetic groups showed two folds
increase of fasting plasma glucose concentrations
comparing with control group.
Both diabetogens can induce diabetes in rat. In the
following experiments we concentrated our works on
streptozotocin-inckuced diabetes because the time
required to induce diabetes is less consuming when using
streptozotocin than alloxan.
TABLE 1
Comparison of Fasting Plasma Glucose Concentration between Normal and Diabetic Rats.
Groups Fasting Plasma Glucose
Concentration (mgdl)






Al 1 o x an -in du c e d
56.1 + 5.8 (6)
115-6 + 12.6 (6)
110.8 + 20.5 (6)
P 0.001
P 0.001
To further prove that rate render diabetes after
31reptozotocin injection, g 1ucose to 1.erance test
end plasma insulin concentration were performed.
X nT~} 1 i op Q p mn d p -p a y~|. AA rp p Q t— v_T ..w ai v—- a.-' ——a i- u. i. V-- » JL. o
diucose tolerance test was performed on control
and streptozotociri-induced diabetic rats. As shown
in fig. 1, the diabetic rat showed impaired glucose
t o 10 r an cs «
3• Plasma Insulin ConcentrationI— w I mr rr,'ini«.»iwi»-i i M.WtoiyirgaHyaiHi
Since streptozotoeIn has been reported to destroy
the 3 -cells of pancreas-in rats (-Karunanayake, 1976)
the effects of glucose in stimulating insulin-secretion
were tested in control and diabetic rats.
As shown in Pia. 2, the fasting olasma insulin
concentration oi diabetic rat is 2 xi Uml . There vas
no response of insulin secretion to glucose injection
in diabetic rat. In norma1 rat, the Insu1in secretion
reached maximum at 20 minutes after glucose injection.
4. Occurrence of Echinocytes in Diabetes
(a) Morphological Studies 'of Rat Erythrocyte
Heparin.].zed blood was diluted 200 fold with 0.01M
phosphate (pH72 vith 10% BSA) and the morphology of
35
Fib. 1 Glucose tolerance test was performed as
described in Materials and Methods (p. 9)














Time after Glucose Injection (min. }
Fig. 2 Measurement of insulin secretion in
response to glucose was performed as described
in Mat e ra1s and Me thod s (p 9).
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e rythro cy t e 3 was o b s e rve d under mic r os c ope.
Fig.3(a) shows that erythrocytes obtained from the
norrna 1 rat ao oeared in the sha oe o£ biconcave discs:
-j- — 7
no morphologica1 abnormalities cou1d be observed.
Fig.3(b) shows the morpho1ogy of erythrocytes oi
severe dia'betic rat, all ervthro cvtes were in the? w kJ
forms of ec.hi.nocytes ( crenated red cells, i.e. red
cells having a serrated outline, with small projections
more or less evenly spaced over the circumference,
see Veinstein, 1974) Table 2 shows the echinocyte
percentage in normal and diabetic rats. No echinocytej. cu o
can be observed in normal rats. Both high echinocyte
contents were observed in streptozotocin and alloxan-
indac e d diabe tic rats.
(b) In-vitro Effect of the Diabetogens on Erythrocytem ii jjnniri-wr - hi n ii ii i urn i n n anr i i mi l i i i 11 r i i —1 n 1 ——- »- . ...... - W
Morphology
In order to clarify whether the aopearnace ofyj ... ..i.
echinocytes in diabetic rats is due to diabetogen-
V
erythrocytes direct interactions or Insulin insufficiency,
the following experiment has been performed. Heparin!zedJ -L ..L.
blood was Incubated in vitro with streptozotocin or¬
al 1 o.x an at room temperature. Since it has been reported«»•
that streptozotocin has half-life of about one hour
in vivo (Karunanayaka e_t al. , 1976), the effect of
Pig. 3(a) Morphology of erythrocyte of normal
rat. Erythrocytes are in shapes of biconcavei f J-
disc with smooth circumference
$ig. 3(b) Morphology of erythrocyte of diabetic: rat.
This preparation was outamed from a rat with severe
i
diabetes (fasting plasma glucose 200 mgd1). Most
erythrocytes were at echinocyfe stage. They are
characterized by irregularity of circumference®
TABLE 2
Appearance of Echinocytes in Diabetic Rats Induced by Streptozotocin and Alloxan.





Streptozotocin-induced 45-7 ± 36.4 (6)
(range 15-90)
P 0.001
Alioxan-indue ed 78.8 + 13.9 (4)
(range 65-90)
P 0.001
diabetogens on erythrocytes v;as observed in oneCO
h o u r p e r 1 o d. as s h o w n i n T c i b 1 e 3 , b o t h s t r e p t o z o t o c i n
and alloxan do not caus- echinocytes formation throughout
in vitro incubation.
R ho tprrri i r« q ~r i p p f h o 7 r»yr +- V~. v,p p r p Q p p pJL v..-- w -L s . «_L U J j, i. J J- U iiv -i- y O i j.o_. v. v.- j u w kU a. mP»n'»I—iui.mi»n»|I—j lira—nih.W»»11HMiii«ii»»•ITM—HM..uliglMIMH1»««H'WM.XIIWwioiKWUMWM—DttMa—mtlMimillOW
0omoarison of ervthrocyte shaoe charac teristicsA.
among the normal, diabetic, and diabetic with insulin
t r e a t n e n t r a t s i s s u rnr i a r i zed i n T a b 1 e 4. (J o m p a r i. n y
with normal erythrocytes, the echinocy tes of diabetic
rats had significantly smaller mean comuscular volumea a.
(1107), mean corpuscular diameter (MOD), surface area
and surface area to volume ratio but significantly,
higher mean corouscu 1 ar averaye thi c 1 cness (HCAT) .—i -i. —
In diabetic with insulin treatment group, the echi.nocyte
oercentaye decreased by about four fold comparing with.L v J.
diabetic group. Erythrocyte MGV, MCD, surface area
and surface area to volume ratio increased while KGAI
decreased significantly. It seems that insulin treatment
can render erythrocyte morphology resuming to normal.
6. Hernog 1 obin Concenzration
As shown in Table 5, hemoglobin concentration of
liabetic group significant!y increased in comparison
1 , . . •% T -1 T -i- T -4-1 -4- -I v I'l 4-V.
T vr o -f- ry 1 % Echinocyte appearance at the time after additic
of diabetogen
'f
Control ( blood )
Blood + Streptozotocin (l.5nigml )
Blood' + Alloxan (1.ml )
(
(
i mm mill 11 i»nm —mitm, —»iiii i iimiii mi n i nunii i in 111 i i ||— ilin i — — | 1 i i —»i n ~ 1 —ni i i r — ... ' ..... — • - -
W
Heparinized blood (300 USPK unitsml) was used in all preparations to avoid clotting.
The amount of diabetogens added to the blood was based on the following calculation. For in
vivo studies, 30mg of streptozotocin or alloxan was administered to rats weighing 300g in
order to induce diabetes. Blood volume of the rats weighing 300g was estimated (Selcher,
et al., see material and method) to be 20ml. Therefore, 1.5mgml diabetogens were used for
in vitro incubation.
TABLE 4
Echinocyte Percentage, Mean Corpuscular Volume (MCV), Mean Corpuscular Diameter (MCD), Mean Corpuscular
Average Thickness (MCAT), Surface Area, and Surface Area to Volume Ratio of Control, Diabetic and Diabetic
with Insulin Treatment Rats.
Groups Echinocyte
Percentage
MCV MCD MCAT Surf ace Surface Area to
Vrl nmo Rq f i r
(cm3) (m) (wm) ( 1) ( A'1)
Control o (6) 71.4+ 1-9(6) 8.8+ o.l(6) 1.19± 0.02(6)
to
1.53 X 101 2.14 X 10 4
Diabetic 45.7+36.4(6)
(range 15-90)
64.1+ 4.9(6) 7.0+ 0.9(6) 1.66+ 0.06(6)
10






68.4+ 2.6(6) 8.6+ 0.4(6) 1.18+ 0.07(6)' 1.47 x io10 2. IS x 10 4
P values of the difference between control and diabetic groups are statistically significant.
P values of the difference between diabetic and diabetic with insulin treatment groups are statistically
significant.
TABLE 5
Hemoglobin (Hb) Concentration mid Hematocrit in the Blood of Normal, Diabetic, and Diabetic









16.31 ± 0.94 (6)
I
18.91 ± 0.35 (6)
15.26 + O.98 (5)
42.6 +2.3 (6)
48.6 + 4.3 (6)
41.5 ± 1.5 (5)
P value of the difference between the control and the diabetic groups is statistically
significant.
P value of the difference between the diabetic and the diabetic with insulin treatment
groups is statistically significant.
with control group. Insulin treatment rendered
hemoglobin concentration back to normal..
In hematocrit studies, diabetic group showed the
increase of hematocrit in comparison with control
group. He ma t o c r i t o f d i a b e t i c gr o up c ha ng e (I b a c k
to normal after insulin treatment. However, both
changes were not statistically significant.
7. Determination of Glucose-6-phosphate Dehydrogenase'i»ib%iwfi'wninnwiBTiiniiiiiniwoiwiinnn»imimiiin'mni i~in~inrOif~iiiitimnilfnnii tmi rrwriinrmnrmirimr'rMn—n-mn'V«c.%rwrtrt«-r--
(G-6-P-DH) and Acetvlcho1inesterate (AchE) Activities
of Erythrocyte
As shown in fable 6, erythrocyte G-6-P-DH activity
significantly decreased by about 27% and erythrocyte
AchE activities significantly decreased by about 36%
in diabetic group in comparison with control group.
Both activities of these enzymes could be resumed
when diabetic rats were treated with insulin.
8» Ery thro cyt e G-luta thi o ne (G-SH)EDMU'WBum.,T-r~-.v-.Ttri—[rriwn-x«»illfr.-i»n iwiwnm-tin. inr»n«..i«n»i.fini«i»»rftnr-jitfniitn- nm«-infi—»ni-|-riiiifT»-»imri--fn—r
As shown in fable 6, glutathione content of erythrocytes
in diabetic rats was not quite different from those in
normal rats and diabetic rats after insulin treatment.
9, Lipid Extraction of Erythrocyte
fable 7 shows the lipid content of erythrocyte
TABLE 6
Glucose-6-phosphate Dehydrogenase (G-6-P-DH), Acetyl-cholinesterase (AchE) Activities and










Insulin TreatmentIll I II !!I IIMII'IIiwIIBIWIIBIWIIIIIUBIi iiiwiiiin
17.16 + 1.53 (8)
i
12.57 + 1.95 (10)
16.62 + 2.57 (5)
4. 20 + 0.82 ( 6)
2.67 + O.48 (6)
3.36 + 0.13 (5)
9.85 + 1.14 (7)
10.45 ± 1-24 (8)
12. 20 + 1.85 (5)
P values of the differences between the control and the diabetic groups are statistically
«i on a -p-j pant
P values of the differences between the diabetic and the diabetic with insulin treatment
groups are statistically significant.
AchE activity is expressed as nmole substrate (Acetylthiocholine iodide) being hydrolyzed ruin aHb.
TABLE 7










P values of the differences» —p~araf—'in——mmmmi —i 1 mmmi —iw——w ! mji
between the control and thea | - ———i na —TP—twwi—iw ——11 up n ii i wnami
diabetic groups
9.48 + 1.15 (6)
8.76 + 1.61 (5)
not significant
5.95 ± 0.85 (6)
4-40 + O.44 (5)
0.001 P0.01
0.63 + 0.07 (6)
0.50 + 0.03 (5)
0.00 I PC0.01
Calculated from standards : molecular weight of cholesterol = 386.6 , molecular weight
of dipalmitoyl-lecithin from bovine brain = 823.84 .
membranes of normaI and diabetic rats. Phospho11pId
content was not significantly reduced in diabeticno v
rat erythrocyte membranes. However, Cholesterol
content was decreased significantly by 26% in diabetic
group. Cho1estero1phospho1ipid mo1ar ratio was a1so
reduced significan11y by about 21% in diabe tic grouo.
10. G-l u c o s e U o t a k e
glucose uptake of erythrocytes in normal and diabetic
rats is demonstrated in Table 8. It was found that
glucose uotake of erythrocytes in diabetic ratscm ,i. v
significantly decreased comparing with normal ratO v j.. CO
e r v t hr o c y t e s „
11. Phosphofruetokinase (PPK) and Pyruvate Kinase (PK)
Activities of Erythrocytes
As shown in Table 8, PPK activities decreased
slightly but not significantly in diabetic rat
erythrocytes, whereas PK activities significantly
decreased by about 34%.
12. E r y throc vte AfP C o nt e nt
as listed in Table 8, erythrocyte ATP content of
diabetic- rats decreased significantly by about 30%
as compared to the control group.
TABLE 8
Glucose Uptake by Erythrocytes and ATP Content, Phosphofructokinase (PFK) and Pyruvate Kinase (PK)












P values of the















lp . PI a 3 ma N - a c e tyl - ; - - ?; 1 u cos am i n i d a s e A c t i v i t y
Table 9 shows the plasma N-acetyl- ft -glucosaminiase
activities in normal and diabetic rats. Plasma enzyme
activi ty in diabetic rats increc sod sign.1 f ican11 y
by about 70% as compared to the control group
14. I mmun e Re s ponse o 1' Dia be ti c Ra. t s
I O Q ' o n ft .o 1 T H ~5~ CV -a, y O f J Oi J- M O ±c' U O O7 ....
As demonstrated in Table 10, wet weight of spleen
obtained from diabetic rats was significantly reduced
t
by about 60% comparing with those of normal rats,
Q l rri 1 1 At v H P P Y P P Z A- 1 V1 Q p~j p p o v; p i rr }j T c: p o cr -f- y p -o p P Z P r o p 0 voJu ' .V-
induced severe diabetic mice has been reported by
Is hibashi e t al. (1980),
(b) Biastogenesis of Spleen and Lymrh Node Lymphocytesf»MUWii»iii'iiimn»U»HS—mm»wiunriiw»ipi.iii hmi»iWWihiihAit h—-m-iTiaim—iMPfiiirrn-rrnm-i riVlii rmnOiTTr-ir-I'rtBt—miwwfoww«rr—»wwfairtfwuwowir
o f N o r m a 1 and Pi a b e t ic Rats
Lymphocytes were obtained from soleen and ivrnohW Jk. S —
nodes of the rat as described in materials and methods,
The optimal concentrations of Concanavalin A (Con A)
for biastogenesis were tested, Pig4 shows the
relationship between the degree of bidstogenesis of
lymphocytes from spleen and the Con A concentration,
A bi-phasic curve was obtained. Two optimal concentrations
TABLE 9
Plasma N-Acetyl- o -Glucosaminidase Activities in Normal and Diabetic (Alioxan-indueed) Pvats.
Control Diabetic P value of the
difference between
the control and the
diabetic groups
Enzyme activityraar3 m.mJWui-fcuir I iHMWPMwm
X .






The substrate used in this assay is 4-methylumbelliferone-N-acetyl- -3 -glucosamine.
TABLE 10





P values of the difference
between two groupsm'v i UM—' i i nLmwi
2.14 + 0.42 (5)
0.83 + 0,28 (6)
P 0.001
55
Fig, 4 Optimal concentration of Concanavalin A
(Con A) on blastogenesis of lymphocyte s obtaining
from normal rat spleen.
5 x 10 6 cells wereFor each Con A concentration,
















































% r% £Kt«3 trJ 3 ajs o rnl
namely 1 Sagml and 33jugml, were recorded. 18pgml
was used as the optimal concentration throughout
our exper1me r11s.
Fig.5 shovs the relationship between the degree
of blastogenesis of lymphocytes from lymph nodes
and the Con A concentration. 9p.gml was the optimal
concentratio n.
Lvmphocytes from soleen and lymph nodes wereJ -J. ....
stimulated by Con A at concentration of 18 and
9ugml re spective 1 y. Af ter 4-8 ho urs incubation,
-VI
0.5 uC i o f K -1 hym i d i n e wa s a d d e d - Af t e r 6 ho ur s,
the radioactivity incorporated in the cells was
estimated. Table 11 shows the result obtaining
fro:n norma 1 and diabe tic rats , B1 astogenesis of
lymphocytes from spieen and lymph nodes of diabetic
rats was significantly lower than that of normals J J
rats. This may imply an impaired immune response exist
in diabe tic rats.
15. Neuro ehernica 1 S tudies of Diale ti c Rats .
(a) (f -A rn I n o - n - b u t y ric a c i d (G A B A) i n P a n c r e a tic Tissue
It has been reported that the G-A..BA concentration
in pancreas was significantly reduced by five-folds
in streptozotocin-induced diabetic rats (Berber and
58
Fig. 5 Optimal concentration. of Cozcanawalin A
(Con A) on blastogenesis of lymphocytes obtaining
fom normal rat lvnmDh nodes.
5 x 10 6 cells wercFor each Con A concentration
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TABLE 11
Comparison of Concanavalin A ( Con A ) Stimulated Blastogenesis between Normal and Diabetic
Rat Lymphocytes.











P values of the differencemiiTiiri ii ! i Tuaiimf-—i r mii ii-hit piiiihwhinrnrnii »mhhii
between the control and the
diabetic
'miK—iwwwwmmmagmmtd
4720 + 532 (5)K29U)
1204 + 234 ( 4)
P 0.001
3187 ± 495 (4)
1238 + 580 (4)
0.001 P 0.01
Hare, 1979). Whether similar change could he observe.'!
in alloxan-induced diabetic rats was under investigafcion.
A11oxan-induced diabetic rats xnd norma1 rats were
fastea overnight, They were ki11ed by dccaoitation'J _L
Q yo ,-y 4- 1 o. Vh Id r y o Q c?- nr Q cj Yn o rmo r Cj r] i To re i o ~i ct1 rs ml ' .• •»-» f c kj L -»j.. vU. yj x v. k.' »—»•—. k v,- C-Wo ' at .1. 1 i' i %«) V k M. «, 1 i. i ww.A -,t .v - kx f.j d r. c k.o vv •..«»o
Vs xa rp 7 rm £? vy 1 7 »o ,1 7 y ml TJ 1 iVl T v A V'i n n - •' r m- 4 i r» o r 1 mi cj vn rixlUii.akt UIjCU .111 A. j ill ui 1 ri U. i WlU.ai Ukt til aLiU. clilU.
-..X
c e n t r i f u g e d. T h e G AB A c o n c e n t r a t i o n o f t h e s u p e r n a t a n t
w a s d e t e r rn i n e d b y e n z y ma tic m e t h o d a• d e s c r i b e d i nV,- !.
M a t e r i a 1 s a n d M e t h o d 5
Table 12 shows the pancreatic GABa concentration
of normal and diabetic rats. A seven-fold redaction
was observed in diabetic rats as compared with normal.
!his resu 11 was in consistent wi th th.at of Gerber and
Hare (1979).
(ft; if-Amino-n-ftutyric acid (GAM) in Brain Regions
a11oxan-induced diabetic rats were used. GABA contenti
in cerebral cortex, cerebellum and striatum were
analyzed and compared, with control, Table 13 shows
the results, The GABA concentrations of brain regions
of contro1 rats are in consistent wita the data reported
by 'Taniguchi and Gkada (1979) . Diabetic rats showed
reduction of GABA content in various brain regions
comparing with control. GABA. content in cerebellum
of diabetic rat was significantly reduced by three
TABLE 12
GABA Concentration of Pancreas of Normal and Diabetic Rats.





P value of the differenceiBiwiwm —i —n——!11m mu. tm wmcammtHB
between two groups
0.49 ± 0.24 (10)
0.07 ± 0.09 (10)
P 0.001
TABLE 13










P values of the difference
between two groups
1.30 + 0.31 (10)
1.05 + 0.30 (10)
0.02 P 0.05
1.40 + 0.50 (10)
0.50 + 0.S6 (10)
0.001 P 0.01
6.05 + 0.95 (10)
0.25 + 0.86 (10)
p : 0.001
fo1ds of the control. Furthermore there was drag tic
reduction on G-ABA content in striatum of diabetic
rat. A twent v-f our fo1d of reduction in aiabeticV-
cr i'} r ;-i cj on'n nfi w ? t r T-rr ] d 0 ta pyrofly-aj x. ci kJ cX Li UG'Cj_ h, «,J. v» ..u 0 11. fv .J J U.l -.A _L Vv • O .J o a. v Li' J. -A.
( c) Brain $erotonin and TryptoohanV' -
Table 14 shows the whole brair:, serotonin and
tryptophan contents in normal and diabetic rats.-A.
No significant difference could be observed in brain
serotonin content between the control and diabetic
rats. However, brain tryptophan content in di - a betic
rats was significantly reduced by nearly two fold
as compared wi th contro 1«
(d) Uptake of Neurotransmitters in Brain HomogenatesimvtoaiSkfVmmtmSWMUMWWBwmMW—m m—urnwwwMaBm—Hn—in »»wmwwwv'iwiiwwiiBMMMiSiw iiiMawaaaiwwJWWiwiwiW'i'
Diabetic rats show significant decreases of GABA
in cerebellum and striatum and tryptophan in whole
brain as comparea with contro 1. The reasons of these
changes were studied. Concentration of neurotransmitters
in the brain is maintained by a balance between
mechanisms of uptake, synthesis and breakdown
(Hammerschlag et al., 1976). Only the uptake mechanism
has been investigated and reported herewith.
Synaptosomal preparations (P9 preparations) of
TABLE 14







P values of the difference
between two groups
4.90 + 0.10 (5)
4.96 + 0.12 (6)
Not significant
28.0 + 2.5 (5)
16.5 ± 3-5 (6)
P 0.001
whole brain or various brain sections of control
and diabe tic rats were prepared a3 deccribed in
lateria 1 s and lie thods . Those pre 0aralionc were
allowed to incubate with radioactive neurotransmitters„
The uptake of those neurotransmitters in the synaptosomal-J- V I.
(P0) preparati0ns was determined,XL
Table 15 shows the GABA uptake of synaptosomal (Pp)
preoarations of brain regions of normal ano diabeticJ_ — (. J
-- o -p a? ]i o. y i rrvj 1 i p p n p] ? -p f p p to p p ay o. c: p H p rTr p rj 1 p ft A 7} Ai_ OO®Jrj O ip} i [J i~ —„ 0 un v u L .i~ a. J., vy i I L- O G g J- - g G. -i_ 1 i. va x X. - a.
1 ] n 1 P 1 p P 7 f n 1 1 r- R h P P R P f' P P R P o r-a V. y»; p p -p ~r p y- p- y, pea G uajvb a ~a v_, v G nu ;J.n v- ;r l a, G J._ X. l . G _L C • G,._L n- -L. 'v n-
_»w .
s t r i a t u m o i n o r m a 1 a n d d i a b e t i c g r o u p s . H o w e v e r, G- A B A
uptake of P0 oresanation of cerebellum of diabeticI -
rats was significan11y reauced as cornpared with contro1.
The brain GABA concentration of diabetic rats as compared
with normal rats show no change in cerebral cortex and
R 1 .G n 5 t'' 1 P 'A ry 4 R p p 7-» p -o p p o r p o -p p h p 1 1 ] ] y f rP p o B p 1 -7 rP p p p, j-t , I. a. .J —L.g v~ 4- 1 i 'wi- ' -A—wl. -i. i. -L KVt —jL- Ln. i i -» s—J—,1 - j 9f --i— 1 i —v
I
results can be exolained by the GABA uptake data asJt. O
listed in Table 15. GABA uptake of cerebral cortex
preparations were in similar extent of diabetic and
control group whereas the uptake of cerebellum was
significant reduced in the diabetic group. Table 13
also shows that there was a drastic decrease of GABA
content in striatum of diabetic rats as compared with
control. However no significant difference can be
TABLE 15









P values of the difference
between two groups
1452.4 ± 490.5 (7)
1378.5 ± 231.6 (9)
Not significant
356.7 ± 51.0 (8)
226.1 + 44.l (10)
P 0.001
1586.1 + 344.0 (8)
1240.6 + 237.1 (10)
Not significant
3
0.025 uCi of ' H-GABA were incubated with O.lmg synaptosomal (P ) preparations of brain
regions for 30 minutes.
observed in the G-aBa uptake of P0 preparations of
striatum of control end diabetic group (Table 15).
This would imply that the G-ABA concentration of
striatum might not he controlled by the uptake
mechanism.
Table 16 shows the serotonin and tryptophan uptake
by s ynap•to s orna 1 (P9) pre parati on of who 1 e brai n of
71 n m ; i ~j vp H '] C o r i p p p V c; TT p i y 70 p T p P 0 n -h -1 1 f1 1° o ,0 V} P pi f- - » 4C--1. ...U x A. vx CAa, v -L. $ J.. 4 k ,) __i_ .[ «. a., 1. _i—v-A i. —b v-L _j,.. —.-,l. v. i i c -
was observed on both neurotransmitter uptake in
normal und diabetic vrour. Brain tryptophan concentration- _ -v. -w _!.
of diabetic rats have been shown to be less than that
of normal (Table 14). No change in uptake may also
i nd i ca t e t hat t he br ai n co nc e ntrat i o n o f tr yo t o ohan
is not controlled by the uotake rnechanism.
Or and all and Ferns tro rn (1980) reported that
streetozotocin-induced diabetic rats were unab1e to
.L
exert normal carbohydrate-induced increments in brain
serotonin and tryptophan. This implies that the
synthesis mechanism of serotonin and tryptophana.1.
m i g h t b e i rn p a i red i n d i a b e t i c rats.•— -t.
TABLE 16








P values of the difference
between two groups
2350.9 ± 294.8 (10)
2144.3 + 264.3 (11)
Not significant
2408.7 ± 419.6 (10)
2994.2 + 246.9 (11)
Not significant
3 11
0.025 uCi of H-serotonin and 0.025 uCi of C—tryptophan were incubated with O.lmg
synaptosomal (Ppreparations of whole brain for 30 minutes.
IV. D;i scussion
1 • Change in Erythrocyte Morphology in Diabet. c Rats— » M I J-i- iL—I
During the streptozotocin and alloxan induction
experiments, urine and blood g 1 ucose, g 1 ucose tolerance:
test and blood insulin were determined to confirm
the induction of diabetes in the exper 1.mental animals
Except some animals which were apparently not made
diabetic and were excluded in our experiment, all
experimental animals experienced a rise in blood
glucose, impaired glucose tolerance test and impaired
insulin-induced glucose secretion and were glycosuria
Significant changes of erythrocyte morpho1ogy were
abserved in diabetic rats. Normal erythrocytes are
in the forrn of discocytes i • e in shapes c f biconcave
disc with smooth circumference (Figpa)?Erythrocytes
of diabetic rats exhibit changes from discocytes to
echinocytes, i.e., the surface bearing projectionsi
or spicules (Bessis,1975; Fig 3b)• These irregularities
of circumference of the erythrocytes could be observed
both in streptozotocin and alloxan induced diabetic
rats' with higher incidence in alloxan-induced diabetes
(Table 2)
Echinocyte formation has been proven to be related
directly to the diseased condition of diabetes
rat h e r t h a n the i n t e r a c t i o n o f t h e d i a b e t o g e n s vi t h
the erythrocytes. We have observed that direct
incubation of s treptozotoci.n and a 11 oxan vi th
heparin!zed erythrocytes would not cause formation
of echinocyte (Table 3) and the percentage of
echinocytes of diabetic rats could be reduced after
insulin treatment (Table L.),
The mo mho logical changes of erythrocytes ofX t J ) KJ
diabetes were further characterized by various
parameters. Diabetic erythrocytes exhibit reduced
va 1 ues of mean corpuscu. 1 ar volume (MCV) , mean
cornuscu 1 ar diameter (MCD) 5 surface area and surface
area to volume ratio but increased mean corpuscular
average thickness (MCAT) when compared with control
erythrocytes (Table if).
The dynamic properties of the erythrocyte membrane
in diabetic patients have been widely investigated,
F or ex am pie, S c hrn i d - S c h o n b ein a n d V olger (1976) a n di
McMi11an et al. (1978) reported reduced erythrocyte
deformability in diabetic patients, Barnes et al.
(1977) and Bab a et al. (1979) showed th at significant1y
higher levels of erythrocyte membrane microviscosity
were found in diabetic patients when compared with
controls. Erythrocyte deformability is defined as
those geometric and physical characteristics that
permit the cell to pass through the anatomically
restricted rcgionsofthe microcirculaticn and it
hag been r epo r t e d that c rythro c ytes in the discocy t e
.form are more deform able and in the echinocyte form
a r e 1 e s s d e f o r m a b 1 e (s e e i1 e v i e w b y B e s s 1 s a n d M o h a n d a s ,
1 975) Hovie ver, the inci denee o f ech 1 nocytes in
di a b etic ~o a t i e n t s h a s n o t y e t bee n i n v e s t i g a ted
In studying of human erythrocytes, discocyte-
echinocyte transformation have been reported to be
induced by the fo11cwing factors:
(i) aging (Choy et al. 1979);
(ii) intracellular ATP depletion (Nakao, 1960, 1961;
Nakao, 1962; Deuticke, 1968);
(iii) change in choiesterol content (Bessis}1973)•
Whether the above three factors take place in effecting
the morpho1ogica1 changes of ery throcyte of diabe tic
rats have been investigated
H urn an e r y throe y te aging is a c c o rn p a n i e d vi t h d e c r ease s
in glr.cose-6-phosphate dehydrogenase (G-6-P-DH) and
acetyl-cholines t erase (AchE) activities (Choy et al
1979) and decrease in glutathione (GSH) concentration
(Beulter et al. 11). Table 6 shows that G-6-P-DH
and AchE activities exhibit significant decreasesv—'
in diabetic erythrocyte as compared vith control
These activities can be recovered after insulin
treatment. It is of interest to note that percentage
of echinocyte can be decreased 1n diabetic rats after
insulin treatment. These results seem to imply that
aging of erythrocyte may be one of factors that cause
e c hino c y t e f o rma tion in diabe tic ra t s. Un e x pe c ted1y,
no change in GSK con t ent o f erv111rocyte o f contro1v—' v yJ
and diabctes couId be observed; the reason of this
discrepancy is not clear.
Aging of erythrocyte in diabetic rats can further-
be proven by the data reported by Chandramonli and
Carter (1975) that sialic acid contents of erythrocyte
m em b r an e declin e a srn a 11 b u t si gn i f i c a. n t am o u n t i n
diabetic rat s as c ompare d to c on tro 1. Si a 1 i c
acid content in old erythrocyte has been found to be
reduccd as compared with young erythrocyte (Choy,1979)•
The second factor that may cause echinocyte formation
is intracellular ATP depletion. Erythrocytes obtain.1. u o
energy from the metabolism of glucose. The factors
contro 11 ing the glucose metaboli.srn, namely glucose
uptake end the enzymes involved in the glucose
metabolic pathways were under investigation
As shown in Table 8, the ability of glucose uptake
decrease significan11y in diabetic erythrocytes
vhen cornpared w 11h control. The exact mechanism of
glucose uptake by erythrocyte is still speculative®
It has recently been shown that insulin receptors are
also present on circulating human erythrocytes (Gambhir
Archer, 1978; Lauro et al«, 1979)- Diabetes is
associated with a loos of insulin receptors on
t he er y throc y t e membrane ( De oip ro e t a 1 • 1980).'J rj — — —
It is not clear whether the decrease of glucose
u p t a k e b y e r y t h r o c y t e o f d i a b e t e s i s r e 1 a t e d t o
low insulin concentration in plasma or reduced insulin
rec e otors on ervthro cyt e mcmbran e•
Two glucose metabolic pathways take place in
erythrocy t e ; na.m e 1 y , t.he g 1 yco 1 y ti c pathway and
the hexose mono ohoispha Ie oxidati ve pathway (Brewer,
197k)• G-6-P-DH is the enzyme that catalyzes the first
s t e p f o r th e en t ry o f g 1 u c o s e - 6 - ph oPph a t e i. n t o t h e
hexose mono pho-j?phat e pat hway Its decline in activity
(as shown in Tab1e 6) and o ther glycolytic enzymes5
name1y phosphofructokinase (PFK) and pyruvate kinase
(PK) (as shown in Table 8) may cause a decrease of
ATP content in ery throc vte o f diabetic .rats®
Table 8 shows that ATP er£ diabetic erythrocytes is» KJ
s i g n i f i c an 11 y s m a Her t h an c o n t r o 1 • T h is decrease
may be considered as the result of decreased glucose
uptake together with decline of glucose metabolic
enzymes in diabetic erythrocytes. Since Brecher (1972)
observed that ervthrocyte mirht have echinocyte formKs J
with low intracellular ATP content, the depression
of ATP level consequently results in inducing diabetic
erythrocyte to change morphologically from discocyte-
into echinocyte
Other factor that will lead to discocyte-echinocyte
t r a n s f o rrn a t i on is t h e c h a n g e of 1 i g ± d v i. c o m p o s i tion
of erythrocyte membrane (Bessis, 1973) Table 7
indicates that cholesterol content declines significantly
while phorphcrlipid is unchanged in erythrocyte as
compared to control. This result is in consistent-L
with that reported by Chandramonli and Carter (1975)•
In our present state of 1 nowletge it is reasonab1e
to consi der thr ee 1 ay ers v;i thin ery throcy t e membran e ,
namely an external layer of glycc-proteins, phospholipid
bilayer stabilized by cholesterol and a layer ofJ t_y
proteins attached to the b:'layer into the interior
of the celis. Various mode 1 s have becn .• jro posed
to account the biconcave shape of erythrocytes and
these invo 1 ve pref er e11 tial di stribu tion o f choJI. estor• o 1
a 1 ong the circumferentia]. belt at the equator of
th.e red cell disc (Bessis and Mohandas, 1 975) •
How the decrease in cholesterol affects the morphology
of the erythrocyte is not clear. The external layeri. t.
of glycoproteins of erythrocyte may also be changed
in diabetes. Chandramou1i and Carter (1975) reported
that sialic acid contents Qf erythrocyte membraneij w
decline significantly in diabetic rats as compared
to c on t ro 1 • We also fo u n d t ha t 1 asrna N- a c e t y 1-p-
g1u cos aminidase ac tivity in c rea s e s significantly
in dia b e tic ra t s (Table 9) This implies N-ace t y1-
B-glucosamine en the external layer of erythrocyte
may decrease in diabetic rats.
All three factors that lead to discocyte-echinocyte
t rans f orrn at ion, n am e 1 y aging, c hange in cho 1 es t ero 1
content and intracellular ATP depletion take place
in diab e tic crythro c vte. The nossib1e im o1ic ationsC C _L.
of these changes in terms of cellul•r function remain
specu].ative at present Since the mechanisms maintaining
normal discocyte form are still obscure, it is
reasonable to state that the causes of echinocyte form
of diabetic erythrocyte is far form being satisfactorily
explained.
2 Immunologic Feature of Diabetic Ratsm—in—inmwanwi —i—i»1i.i nixiiwwmhurTf—i-—i i i~iruni nni i iiminnifc1Tinitii i iwhhiwm»ir.tj..nM«w
We have shown that diabetic rats were associated
with significant decrease in size of spleen (Table 10).
We also noted depression of the lymphocytes obtaining
from spleen and lymph nodes response to Concanavalin A.L v .i. _L
in diabetic rats (Table 11) It is suggestive that
an immunosuppressant effect of streptozotocin on-L ~L -J-
1ympho c y t e s appears.
Recentlyj depressed immune responses were stressed
in experimental diabetic mice. For example, Nichols et ai.
( 1979) r e po r t e d t hat s t r e p'to zo to ci n -in du c e d mi c e
have large decrease in the size and the nucleated
cell content of the thymus and sp1een. Ishibashi et a1•
(1980) showed th at delay in the proliferation and
differentiation of lymphoid cells occurs in streptozotocin-
induced mice.
Clinically, investigators noted depression of the
lymphocyte response to antigen in diabetic patients
(Casey et al • 1977)? suggesting impaired cell-mediated
immunity. The increased susceptibility of diabetic
patients to both bacterial and mycotic infections is
well documented. The reason for this increased
susceotibillty to infections is not clearly elucidated•.i.
Howe ver, num cro u s vork ors r epo r t e d tha I i t sho u 1 d b e
ascribed to malfunction of the polymorphonuclear
leukocyte (Bagdade ct al• 1978; Nolan et al. 1978)•
The possible mechanisms of immunodepression in terms
of metabolie chan g o s in diabetes have been studied
Several investigators (Thompson, 1 967 ; Hadden et al•
1972; Strorn et al » 1975) reportcd that insu 11.n augments
lymphocyte responses. Treatment with insulin reversed
the decrees!on of antibody : roduction and cell droliferation«— a,
Re ceil 11 y , S e 1 a ffl et al. (1979) used a n e x t e r n a 1 a r t ific i a 1
pancreas to control the optimal blood glucose concentration
of diabetic patients and found that the lyirrohocvtej a 'j
functions' become ndrmal rapidly®. They also . observed
that high glucose concentration in diabetes can suppress
both mitogen stimu 1 ation and T and. B-1 ymphocyte numbers ;
DL-3-hydroxybutyrate, one of the ketone bodies in
diabetic patient, can suppress mitogen responsiveness.
i
Such results suggest a rapidly reversible T-cell
defect closely linked to the existing metabolicKj 4—
disturbances. Thus, the quest for hyperglycaemia and
ketonaemia in diabetes must be the aim of treatment
because long-term complications, such as defects of
cellular immunity are likely to be secondary to
disturbed metabo1ism•
3 • Neuro logical Stud 1e s o f Pi 1 b c 11. c Ra t s
IVe have shown that K-amino-n-butyric acid (GABA)
level s sig 111 fican11 y decueasc.• i i pancreas of diabetic
r a t s a s c 0 rn p a r e d w i 111 c 0 n t r 01 (T a b 1 e 12) 11 h a s
been suggested that GAPA in the endocrine pancreas
is ass0ciated vi th, or c0ntained in , the j3-cell of
the is1et (Gerber and Hare, 1979)• Thus, loss of
this cell in diabetcs cause a sianilie•nt 10ss 0fv.,y
p a n c r e a t i c G A E A
The role of GABA in islet function is not known
at prese nt a na t he corsequc nces c ause d by its absenc e
in diabet es ar e 0 bs cure
II e u r 0 p a t h y i s a f r e q rent rn a j 0 r c 0111 p lie a t i 0 n 0 f
human diabetes but 1 ittie is 1 •:n0wn 0f its path0genesis•
Consistent detailed information regarding the pathogenesis
o f diabe ti.c anini a 1 rnode 1 s are lacking. IVe have studied
some neurotransmitter contents, namely GABA, tryptophan
and serotonin in the brain and their uptake in the
synaptosomal (P2) preparations of the brain. Results
indicated that GAEA content decreas€i significan11y
in cerebellum and striatum of diabetic rats as
compared with c0ntrol. Brain tryp10phan also decreased
in diabetes while serotonin remained relatively
unchanged (Tab1es 13 ?19)«
GABA is an inhibitory neurotransmitter of the
mammalian central nervous system. This compound acts
to increase inward chloride-ion flux across excitable
m emb ran e, r e su 11 i n g i n h y p e r do 1 a ri z a t i o n a n d 1. n hi b i ti o nJ ' u ».
of ne u r o t r a n s m i tter r e 1. e a s e (G e r b e r a n d H a re, 1979)
Tryptophan is a class of amino acid neurotransmitter
It can be hydroxydated into 5-hydroxytryptophan
( herotouim, 5-HT) . Trypto phan and 5-HT have heen
re oort ed to have sirni.1 ar e f f ec t on brain func tion.
For example, they have been associated with increased
growth horrnone re 1 ease (Arno 1 d and Fernstrom, 1979)
improved s1eep and ana1gesia (Fernstrom and Lytie, 1976)
The reduction of GABA and tryptophan contents in
diabetes may then be an important abnormality.
The decreased content of neurotransmitters may be
due to changes in their uptake, synthesis or breakdown
For in vivo studies, it has been reported that brainSMWM—M. -1
can uptake amino acid neurotransmitters, e.g. tryptophan,
phenylalanine etc. via a transport system at the blood-
br s.i n ba.rrier (Pardri dge , 1977) Trypto phan u ptake
are stimulated by insulin and inhibited by branched-
chain amino acids (Cranda11 and Fernstrom, 1980).
Thus , 1 a c k o f i n s u 1 i n an d i n c r e a s e o f b r an c h e d - c h ai nt'
amino acids in the blood of diabetic rats can
account for the decreased tryptophan uptake resulting
in 1ow content of the brain
For in vitro studies, we have a1so irivestigated
whether .or not prim: ry changes in neurotransmi11or
uptake occurs in the brain tissue. The neurotransmitters
uptake s 1 n t he synapto sorna 1 ( P2 ) pre parati 0ns o f the
brain regi0ns or v;ho 1 e brain v:ere stuclied. Tn gen era 1,
no change could be observed in diabetic rats when
c0mpared vi th n0rma 1 (Table 15,16) It is suggestive
that uatake of neurotransmitters may be controlled
rn 0 r e b y t h e e x tern a 1 e n v i r 0 n i r. e n t, e, g. b 10 0 d i n s u 1 i n etc,,
in diabetic condition than the transport system of
brain itself. The studies of biosynthesis and
breakd0v n 0 f neurotransrni 11ers 0.re 001 ontia 11 y
im0:rtant. Many worivs rre necessary befcre the
pathogenesis of neuropathy of diabetes can be clearly
u n d e r s 10 0 d •
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I. In troduc tiori
Interferon (IF) is de fined as a cellu1ar protein
produced in response to and acting to orevent reeli-• i a. s C.J i j..
cation of an infecting virus within the infected ce 11,
Since its discovery by Isaacs Lindenmann in 1957 a
vast 1iterature has aecumu1ated, Pesearch has con¬
cent r a ted o n t wo m ain are a s - an e x p 1 an ation of the
formation and action of IF in mo1ecu1ar terms, and
the use of IF as a possible clinical antiviral or
anti-1urncur agent s .
1 Pharmacokinetics of 1nterferon
Cantell, Pyha1a 1 Strander (19 7h) an d C an tell 1
Pyhala (1976) studied pharmacokinetics of human
leukocyte IF in rats and rabbits. Serum half-life ofo r
leukocyte IF administered either intravenously or
intramuscularly to rabbits were estimated to be 7
hours. Jordan et_ ah, (197k) reported that a daily
6
intramuscular injection of 80 x 10' units to
patients produced titres of 180 to -j70 unitsml in
serum and they found no IF in the cerebrospinal
fluid of a patient while their IF titre was sus¬
tained at 278 unitsml.
Recent investigations indicated that the liver is
the site for the clearance of human fibroblast IF
when injected in 111 e animal (Bocci et a1. 1977a),
Bocci et al• (1977b ) further found that the asia1o
human fibroblast IF, has a shorter half-life in mice
than the native IF which contains sialic acid residues
and that the asialointerferon activity was found to be
accumu 1 ated in the 1 iver 1:o a greater extent than the
n a t i v e IF
2. Clinica1 Aorlieation of Interferon in Man
The prospects of IF as an antiviral substances have
been actively investigated since its discovery. Its
advantages are that it is a relatively non-toxic
substance with a broad, antiviral spectrum, Purifi¬
cation studies indicate that it has a very high
specific activity. Hence it could potentially be a
potent substance with a high therapeutic index, IF
treatments have been reported successful in influenza
(Ho and Armstrong, 1575), chronic hepatitis (Green-
berg et al. , 1976) and dendritic keratitis (Sundmacher
et al•, 1976).
The most successful clinical trial to test the
an t i t urn our effect of IF wa s c o n d u c t e d b y Str an d er et
al. (1976) on the effects of leukocyte IF on osterogenic
sarcoma. 21 patients were first treated surgically and
in some cases with X-ray therapy to reduce the tumour
load and then, they were given between two and three
million units of IF three times a week for 18 months.
None of these patients showed any side effects due to
the IF treatment and among them, there appeared to be
a reduced incidence of metastasis as compared with th
control patients who did not receive IF.
3• Pur nose of S tu dy
Since its discovery, IF has been a subject of
intensive investigation and the ultimate aim of such
effort, at least one of the. initial aims, is the
application of IF as a therapeutic agent to treat
viral diseases of human. During the course of the
investigation, other possible areas of applications
of this potent substance have been identified. It
is now known that IF may have antitumour activity
and this raises the possibility of using IF to treat
h urn an m al i gn an c i e s.
One of the major obstacles to the goals is the
short half-life of IF in vivo. The molecular weightmxWfVUMRgfci »vU
of IF is above 20,000 (Knight, 1976).-It is known that
the renal threshold is about ZfO, 000-60,000. IF can
therefore be easily eliminated by excretion through
kidney (See review by Ho and Armstrong, 1975). It
is oi interest to test whether the pharmacokinetics
of IF would be improved by increasing Its molecular
weight. In this thesis, one experimental approach
towardsthis end will be examined : me111ods have
been tried to produce cova1en11y 1inked dextran -
IF soluble complex. 1,fong and his co-workers have
reported a serIes o f works on solub1e dextran-
hemoglobin (Chang Rc ™ong 1976; Tam e_t al. , 1976;
Tarn et al. , 1978) It has been reported that the
soluble dextran-hemoglobin has a much longer serum
half-life and much smaller excretion rate by the
kidney as compared with the free hemoglobin. If the
above phenomenon also occurs in dextran-IF, it might
be expected to. facilitate the therapeutic applications
of IF, Pressn11y, pharmacokinetics of the comp1exed
IF was studied and compared with that of native IF,
11. M at eria.1. s a n d Me t h o d sXMMiMKTia»|IHI|.W»IHII—,im»I»—HillII
1. Production of Mouse Interferon' » 1 II'—— » m I n m mi mi Ifi aim w nnuMiKtM
Mouse leukocyte interferon ( IF ) was induced
by the method of Cantell and Pyhala ( 1976 ).
Mouse lymphocytes were obtained from spleen,,
They were allowed to incubate with Newcastle
disease virus. The IF released into the culture
medium were harvested and kept at -70°C until
u s e d,
2 Interferon Assay
Mouse L-cell cultures were used for IF assay.
Ricroplate assay method as described by Havell
and Vilcek ( 1972 ) was used. Cells at density
i—
of 1. - 2 x 10y cells per ml were suspended in
growth media® 0,2. ml of the suspension vas seed
in each well on the tissue culture microplates
Incubation was carried out at 37°0 at a humidified
atmosphere with 5% 00~ until near confluent.
Twofold dilution of the samples to be tested were
prepared in media Duplicate cultures were incubated
with 50 ful each of the diluted aliquota for 18
to 20 hours and then inoculated with Vesicular
Stomatitis Virus (VSV) at a multiplicity of.0,1,
97
After 2 days incubation, the culture were scored
for the presence of cytopathic effect. IF activity
expressed in actual "laborato units" ts was the
maximum dilution that affords protection against
VSV induced cytopathic effect.
Preparation of Hemoglobin Solution
(1976)
The method as described by Tara et al4 1976
was used. Blood was obtained from the vein of
rabbit ear and centrifuged. The packed erythrocytes
after washing four times in isotonic saline were
suspended in 1.5 times the original volume of
distilled water. It was then Boni cated for 5 Minutes
in a Sonicater Cell Disruptor (Model 200 P, Plainvie
N.Y., 11803) operating at maximum energy output,
and centrifuged at. 31, 000 x g for 1 hour, The
supernatant was filtered through a 0.2 girls Milli-
pore filter to yield stroma-free hemoglobin.
4. Iodination of Hero clai n
Iodinated hemoglobin was prepared by using the
c Loramine T- sodium metabisulfite method as
originally described by Greenwood and Hunter (1963)
with modifications.
ImCi Na 125 I (carrier free) was added to 0.5 ml
hemog 1 obixi solution (80 mgrn 1) and rnixed vigorously
and continually The reaction was begun by the
addi tion o f 50 j 1 chloramine T (A0 rngm 1 in 0 • 1M
phosphate buf f er, pTT7. A) . 1 xac11 y one rninu te later,
0.2 m 1 of sodiurn metabisu 1 fite (2.5 mgm 1 in 0.1 M
p h o s p h a t e b u f f e r ) wa s add e d. foil o v; e d b y t h e a d d i t i o n
of 0.2 m 1 of potassium iodide (10 mgm 1 in 0 .1M
12
phosphate buffer) as carrier. The free was
-L. —
removed b y filt r a t i o n a G - 50 S e oh a d e x c o 1 urn n ,..L if
e 1 ut1.ng v.i th 0 .1M phosphate buf f er.
5° Formation of Soluble Dextran-Remoglobin Complex (Dx-Hb)
The alkylation method as decribed by Tarn et al.
12
(1976) was followed. 1-Hemoglobin was allowed to
react with activated bromodextran at a ratio of
bromodextran to hemoglobin equals to 0.5A Activated
t
b r o rn o d extra n (m o 1 e c u 1 a r w e i g h t, AO, 000) w a s k i n d 1 y
supplied by Professor J. Tze-fei Wong of Department of
Qiochemistry, University o f Toronto. The reaction was
carried out for 22 hours at AC using aliquot mixer.
The dextran-hemoglobin complex was separated from
unco u pled he rn o g 1 o b i n b y m e a n s o f - chroma t o g r a p h y o n a
S epha d ex G-10 0 colurnn
6• Formation of So 1 ub 1 e I)extran-Mouse Tnterf eron CompI ex
(Dx-IF)
The method as described by T am et a I.. (1976) was
adapted The mouse interferon was dialyzed against 0.1M
bicarbonate buffer, , p H 9 • 5 • Bromodextran was weighed and
mixed with interferon at a mo1ar ratio of activated
bromodextran (Molecular weight, lt0 ,003 ) to inter f eron
o f about 1. The coupling reaction was aliowed to pro ceed
0
at h'C for if8 hours After the reaction, the complex was
dialyzed against phosphate buffer saline (PBS) with 10%
glycerol and 0.5M NaCl. The complex was concentrated by
u 11 r a f i 11 r a t i o n.
T h e d e x t r a. n -interfere n c o m p 1 e x f o r m e d w a s s e p e r a t e d
from native interferon by means of chrornatographv on aV—-'.1.
%
Xephadex G-75 column, eluting WJth 0.1M acetate buffer
with 10% glycerol and 0,5M NaCl, pH 55
7. Sodium Dodecyl Sulphate Polyacrvlamide Gel Electro¬
phoresis
The IP's preparations were ana 1 yzed on so diurn dodecy 1
sulphate (SDS) slab gel (Shapiro et al, 1967) vith an
apparatus purchased from I solab Inc., USA. Gel slabs-X- X -J_
were cast in linear gradient of A - 2k% acrylamide made
up in 0.1 M pho sphate bu f f er p 11 7 • 2 contad.ning 0.1 % SDS
100
Samples were mixed with SDS buffer, saturated sucrose
and bromophenol blue solution before application.
15 -75 g of samples in a volume of 5 - 30 l were
applied. Electrophoresis was performed at 6 volts per
slab for 40 hour. The slabs were sliced. To determine
IF activity, the gel slices were eluted with 0.5 ml of
PES at 4°C for 1 to 2 days, and an aliquot of the
eluate was assayed.
III. Results
1 , Pr eparati on o f Sol uble Padi o ac t1 ve Dext ran-in in hiiiiii i i r~ 1 I'll —iir~ • —ii in i [.aw.vwiMj'waMw vutwvfr'M''
H em o x 1 o bi n C om p I. e x ( D x- H b)
H em o g 1 o b i n (H b) va s pre p a r e d f r o n r a b b i t b 1 o o d
as described in Mat eria 1 s and rnethods . Iodination
was performed by the chloramine-! method (Creenwood.4.
125,
and Hunter, 1963) » Fig. 6 shows that ' v!~Hb so
12
obtained was relatively pure; free I was
separated by gel filtration .
1 25
x~Rb was coupled to dextran by using activatea
bromodextran according to the method of Tam et al
(1976). Activated bromodextran was kind1y supplied
by Professor J. T'ze-fei Wong of Department of biochemi
chemistry, 11 niversity of Toronto . Fig. 7 shows
the chronatography of radioactivendextran-hemoglobin
(Dx-Hb) so formed. Contamination of radioactive
i
Hb was separated by gel filtration. Radioactive
Dx-Hb so formed has specific radioactivity of 3 x 10J
cpmmg Hb.
2. Formation of Soluble Dextran-Mouse interferonr- nn-——nr-n—rmrrtMimfTTm-' ii mihi aminnnmrniwrmgrninri-rmrinii i-~ i nmri i mvinn;n»irnwmpwminkm.mtmm———--nmi»
Conpiex (Dx-IF)
Mouse interferon(IF) was coupled to activated
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Fig. 6 Separation of iodinated hemoglobin (Hb-I 125)
from carrier-free NaT125 by chromatography on
Sephadex G-100. The colum size was 1x20 cm and the
mixture was eluted with 0.1M phosphate buffer (pH 7.4),
at a flow rate of 1 ml/3 min. The extremely high
radioactivity plotted with broken line was observed
at the second peak, which was the portion of carrier-
free NaI125 not coupling to hemoglobin.
The Hb-I125 so prepared has specific radioactivity of











Fig. 7 Separation of dextran--iodinated--hemoglobin
complex (DX-Hb--I125) from the reaction mixture by
chromatography on Sephadex G-100. 54 mg of Hb-1125
(specific radioactivity copm/mg) was allowed
to couple with activated bromodextran as described
in Materials and Methods. The column size was 3x60
cm and the reaction mixture was eluted with 0-05M
phosphate buffer, pH 7.5. The flow rate was
adjusted to 3 ml/ 5 min. Both the absorbance at
and the415 nm
were recorded. The first peak eluted at smaller
elution volume represents the complex whereas the
later peak with low radioactivity was Hb--I125
without coupling to bromodextran.
2.0
1.0







bromodextran (too1ecu1ar weig 1 i1, 80,000) as describec
in Materials and Methods. IF of activity of about
s~
2 x 10° units were incubated with bromodextran.
The Dx-IF so formed was separated from native
interferon by means of chromatography on Sephadex
6-75 column The IF activity in each elution
vo1urne was tested Fig.8 shows that the e1ution
pattern. Comparing the elution position of some
protein markers ( blue d ex trail and myoglobin), the
I)x~TF has a much higher molecular weight than native
IF.
Table 1? summarizes the coupling result. The
coupling efficiency, in terms of IF activity, was
about 85%
The molecular weight of the Dx-IF was determined
by sodium dodecyl sulphate polyacrylarnide gel electro
-phoresis. About 10,000 unit of IF or Dx-IF were»
applied in electrophoresis. After running, the
slab gel was sliced into strips of about 2mm width.
The gel slices were incubated with 0.5 til of PBS
at 8 C for 28 hours. Interferon was eluted and
its activity was measured.
Fig. 9 shows the molecular weight evaluation
of IF and Dx-IF bv using protein markers. TheK CO
native IF was shown to migrate as a 20,000
molecular weight peak and this result was in accord
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Fig. 8 Separation of dextran-interferon (DX--IF)
complex from the native interferon (IF) 6 by
uni tschromatography on Sephadex G-75.
of mouse IF was allowed to couple with activated
bromodextran as described in Materials and
Methods. The coiumn size was 3x60 cm and the
reaction mixture was eluted with 0.1 M. acetate
buffer, pH 5.5, The flow rate was adjusted to
3 ml/5 min. Both the absorbance at 280 nim
and IF activity
were recorded "A" , Dx-IF "B", native IF.
Crrornatography of molecular weight protein Markers
was performed in separated run. C"", blue
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TABLE 17
Coupling Efficiency of Mouse Interferon Coupling with Bromodextran.
Units of mouse IF used for coupling 2x 10/6
Units of Dx-IF remaining after coupling 9 x 10/5
Coupling efficiency 45%
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Fig. 9 SDS--polyacrylamide gel electrophoretic
migration of IF activity observed with nafive
mouse IF or with dextran--IF complex. 10,000
units of activity of native IF or complexed---IF
were applied to a polyacrylamide gel slab and
electroohoresed at 6 volts per slab for 40 hours
at 4°C, The gel was sliced into strips with
2 mm width. The slices we re eluted with PBS and
assayed for interferon activity.
Molscular weight protein markers, thyroglobulin
(Thyr), rabbit immunoglobulin (IgG), bovine se:iirr,
albumin (BSA), ( -chymotrypsinogen (c -chy) and
myoglobulin (Myo) were electrophoresed on a
different slot on the same gel slab. They were



















































with findin g s of oth0r w0rkers (Vi 1 cek el a1. , 1 977 ;
K ni gh t, 1 9 7 5 ) . Th e Dx-I F s h 0 ws a h e t e r 0 g 0 n c 0 u s
peak with molecular weight ranging from 30,000
to 300,000 and the 20,000 n 1 o1ec u1ar w0ight ac tivity
peak of native IF was missing.
3« Pharmacokinetics Studies of Comn1exes Coup1ing»» tf iffTrrmujuntWW1—MMw i-IWUnBHwWfWmnWMOWH—PWHPIWWWimwiWg—B BWttWiwwwwWWWWM—WHww.wL—WH•wtwwi iHaWWwWWKilMBWMBPWtWrw
with Dextrail
(a) Free Hemoa1obin(Hb) and Dextran-heraog1obin(Dx-Kb)
Ramonly bred male Swiss mice weighing approxi¬
mately 25g were given intravenous injection of
radioactive iodine labeled Hb and Dx-JIb in amounts
of 0.2 mp in 0 .1M phosphate buf fer, pH 7«0 9 contain-
ing a total amount of radioactivity, 1 x 10 °cpm.
The anima 1 s wer e ki 1 led at di f f erent t im e s a,nd
radioactivity in the serum specimen was determined
(Fig. 10). The Dx-Hb was removed from circulation
at a greatly reduced rate as compared to Hb. This
result agreed with that of Tarn et al. (1976) .
(b) Native House Interferon(IF) and Dextran-InterferonWWM'lI MlBUMIfIMf.I MWil1t —WI. ill .ini|i~«lI fWWallnim»»I Wl—lrn—unm-Wfl—rmmi'l Wi 11mmrt!UN«nIII!III«.'l»----imm-II M11mwiir.i .-imm—«ri1»1n1.imian.,immn.Mil—
(Dx-IF)
IF or Dx-TF in volume of 0.05 ml PPS containing
activity of 10,000 IF units were intravenously
injected into mice. The animals were bled at
different time intervals and the IF activity in
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Fig.10 Serum clearance of Hb and Dx-Hb in mice.
1x10 6 com of Hb-I125 or Dx-Hb-I125 were injected
intraveneously into mice. Blood were drawn at
different time intervals. The radloactivities
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in the serum specimen was assayed (Fig. 11). The
serum half-life of native mousc interferon observed
in three mice was approximately five hours agreed
with values for human interferon reported by Edy
et al.(1976). Dx-IF also showed the same half-life
as native IF.
As shown in Fig. 11, in animals receiving native
IF or Dx-IF, the maximum serum activity was attained
early at about 10 minutes following injection in
both cases. The level of activities declined there-
after at similar pattern.
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Fig. 11 Serum clearance of mouse IF and DX -IF in
mice. 10,000 units of IF or DX-IF were injected
intraveneously into mice s Blood were dragon at
different time intervals. The interferon activities
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T V. Discussin n
The techniques for covalently coupling hemoglobin
to soluble dextran have been well documented ('Chang
and Wong,1976; Tarn et a1., 1978). The alkylation
method was used to couple mouse IF to soluble dextran.
The chemical steps involved in this method, on the
basis of the known reactions of the reagents used,
are : (Tarn et al • , 1 976 )
D ex t r an + c y an o g e n b r o m i d e a c t i v a t e d d e x t r a n
Activated dextran + diaminoethane ami ii o ethyl -
am i n o d e x t r a n
Ami no e t h vl - , br o rn o a c e t vl -.— v —
am i n o d e x t r a n b r o m i d e
TV - h r n mn p r. p t v 1 - p mi rt n -
e t h y1amino-dextran
f - b r o m o a c e t y 1 am ino-ij
e t h y 1 am i n o - d e x t r a n
interferon-NH-
Interfero n ~ N-acety1 aminoathy1amin o de xt r an
The amino group on interferon participating in. the
above reaction is in analogy with the reaction
between interferon and insoluble Sephadex as describ
-ed by Ankel et ah . (1973) ond Chaily (1977 ) »
These workers have urenared insoluble Senhadex™X -L -L
mouse IF complex by reacting IF and Sephadex gel
wi t h c y a n o g e n b r o rn i d e. The t e r m i n a 1 am ino g r o u p
was
on I J?A expected to form c oval en t bond with insoluble
Seohadex gel. ryihis Sephadex -IF complex retains
i t s a n t i v i r a 1 a c t i. v :i. t y „
The terminal amino-group of IF was reported to be
d i s p e n .s i b 1 e i n i t s a n I i v i r a 1 a c t .1. v i t y ( s e e r e v i e w
by Ho and Armstrong, 1975 ). The Dx-IF so for;:,od
in our experiments also retained its antiviral
ac tivity
Throughout our experiments, we have used activated
bromodextran of mo 1 ecu 1 ar weight L0 ,000 to couo 1 eV 1 ' J
with mouse IF. Mouse IF has been reported to 11ave
r n nn i - r mn'i rrb -f- n P OOO ( I7i I ~ o 1- f o 1 1 O 1 '7 »
i flU i L n. 1 t U .1 dL ) ? UUJ V ; J . ± h. U'i Fl U c-l i. « 5 I 1- ( ?
Knight, 1975) and this r csu 11 was a 1 so coi f irmerJ
i n o u r e x p e r i m c n t (F i g . 9) • H o w e v e r, t h e m o 1 e c u 1 a r
weights of the Dx-IF so formed have molecular weights
ranging; f rorn 8 '•,000 to 300 ,000 (Fig .9) - 7his ini o 1 ics
t h a t m u 11 i p 1 e c: o u p 1 i n g s m a y t ak e p 1 ace.
The bonding between dextran and IF in Dx-IF should
be covalent It is shown by the retaining of IFXS )
a c 11, v i t vr a f t e r S D S - PA G E e 1 e c t r o p h o r e s i s „ T hr o v g h -
o u t e 1 e c t r o p h o resi s , S D S and 2 - m e r c a p t o e t ti a n o 1 s h o u 1 c ]
separate the non-covalent bonds (Shapiro _et ah , 1967)
However, the 20,000 mo1ecu1ar weight activity pcak
which is corresponding to native IF was conspicuously
missing in the Dx-1F ore naration after electr0phoresis
(Fig .9). This indicates that a 11 IF in Dx~IF vas
covalently bound to dextran.
The pharmacokinetic studies of native mouse IF
12 5
a n d D x -1F c 0 m p 1 e x w ere t e s t e d i n n muse. F ree 1 -
12 5
Hb and Dx- y I -H b c om plex were u s e d as c on trol •
Fig. 10 shows that Dx-Hb had a much longer serum
half life than free Hb„ This result agreed exactly
with that of Tarn et al. (1976) o However, as shown
in Fig,11, Dx-TF has similar serum half life of
5 h0urs as na11 ve IF. Mo pro 1011 g 0f half 1 ife was
0bserved In Dx-1F • This rneans that native IF and
Dx-IF were cleared from blood under similar if not
i d e n t i c a 1 m e c h a n i s m•
Since Dx-IF complexes have molecular weights
ranging from 80,000 to 390 5000 while the kidney
t h r e s h 01 d f 0 r p r 01 e i n i s a b 0 u t L-0 ,000 t o 6 0 ,000,
this implies that the active clearance mechanism of
Dx-IF may not be in the kidney.
Recent investigations indicated that the liver
is the site for the clearance of human fibroblast
interferon when injected in the animal (Bocci et_
al., 1977a), Bocci et al(1977b) further found that
the asialo human fibroblast IF, has a shorter
half life in mice than the native IF which contains
sialic acid residues and that the asialointerferon
activity was found to be accumulated in the liver
t o a g r e a i e r e x t e n t t h a n t h e n a t i v e IF .
The clearance of native IF fits very much to the
Ashwell's model (Ashwe11 et al.,197A) for the
removal of serum g1ycoprotein. Hepatocytes(More11,
1966,1971;Stewart II et al.,1977) of the liver
have been reported as a main site for sequestering
0f g1y copro teins• This site rec0gnizes the ga1ac 10se
0 r g a 1 a c 10 s a m i n e m o i e t y 0 f t h e g 1 y c o p 1 • o t c i n s»
Since5 galactose or galactosarnine is always bound
to the terminal sialic acid on the carbohydrate
1inkage of the glycoprotein, g1yc0pr01eins with
similar sialic acid should have similar serum half-
life »
Though the Dx-IF complex so prepared has much
larger molecular weight than native IF, change
of sialic acid content should not be resulted. At
present5 we can only assume that the conformation
of IF does not change in Dx-IF. Thus the number
of galactose or galactosarnine residue(s) recog¬
nized by the hepatocytes should be similar in
native IF and Dx-IF. It is therefore reasonable to
note that the half lives of IF and Dx-IF are
s i m 11 a r.
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Attempts of coupling IF to biomolecules have
been reported by other workers. For examples,
Fung and Ng(1978) has coupled IF to immunoglobin
and Magee(1978) has coupled IF to liposome. In
both cases, though the IF complexes have molecular
weight much larger than native IF, still no prolong
of serum half-life could be resulted.
The result of our present study on the pharmo-
kinetics of Dx-IF though preliminary, had one
interesting aspect;i.e. to prolong the serum half-
lief of IF, one alternate method is to alter its
carbohydrate moeity, for example increase the
sialic acid content, or mask the galactose or
galactosamine moiety; the liver but not the kidney
play an important role on clearance of IF.
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